<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://fn.bmj.com">
<title>FN Online First</title>
<link>http://fn.bmj.com</link>
<description>FN RSS Feed -- Online First</description>
<prism:eIssn>1468-2052</prism:eIssn>
<prism:publicationName>Archives of Disease in Childhood - Fetal and Neonatal Edition</prism:publicationName>
<prism:issn>1359-2998</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301883v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301672v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301695v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301373v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301589v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301142v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301965v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301257v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301340v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301276v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300435v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301066v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301025v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301470v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300539v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301572v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300974v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301218v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301702v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-300989v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301334v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300973v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301758v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301658v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301282v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301309v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301395v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300665v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301580v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301129v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300766v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301482v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300820v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301339v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301479v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300964v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301158v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301126v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300631v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300752v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300763v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300578v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300969v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301090v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300716v2?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300244v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301388v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300907v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301200v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301235v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301464v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301209v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300412v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300405v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301008v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300773v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300872v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300929v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301148v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-301041v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300117v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300822v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300336v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300601v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300532v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300548v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300627v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300121v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300573v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.300492v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300641v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/archdischild-2011-300535v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.209700v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.196451v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.210856v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.214239v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.199703v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.207043v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.208868v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.194100v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.170910v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2011.211649v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2010.188359v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.175109v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2009.180869v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2008.137125v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2006.114009v1?rss=1" />
  <rdf:li rdf:resource="http://fn.bmj.com/cgi/content/short/adc.2006.105577v1?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Fetal and Neonatal Edition</title>
<url>http://hwmaint.fn.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://fn.bmj.com</link>
</image>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301883v1?rss=1">
<title><![CDATA[Drugs used for comfort care after withdrawal of intensive treatment in tertiary neonatal units in the UK]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301883v1?rss=1</link>
<description><![CDATA[<p>Drugs are widely used for the comfort/palliative care after withdrawal of intensive treatment in the neonates.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref> Analgesics and sedatives are commonly used and outside UK, neuromuscular blockers (NMB) are also administered.<cross-ref type="bib" refid="R3">3</cross-ref> The adverse effects of these drugs, which can be life limiting, can cause apprehensions among members of the clinical team. Guidelines published by Royal College of Paediatrics and Child Health (RCPCH) views the use of sedatives (Opioids) as a benefit to control the pain and distress during life and not to hasten the death.<cross-ref type="bib" refid="R4">4</cross-ref> They also highlight that initiation of NMB just before withdrawal of intensive treatment is unethical and unlawful.</p><p>No current data are available regarding the drugs used for comfort care in neonatal intensive care units in UK.</p><sec id="s2"><st>Methods</st><p>We surveyed tertiary neonatal units in the UK from October 2010 to January 2011 for the drugs used for comfort/palliative care...]]></description>
<dc:creator><![CDATA[Chaudhary, R., Silwal, A., Gupta, A., Kelsall, W.]]></dc:creator>
<dc:date>2012-05-11T02:01:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301883</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301883</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Drugs used for comfort care after withdrawal of intensive treatment in tertiary neonatal units in the UK]]></dc:title>
<prism:publicationDate>2012-05-11</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301672v1?rss=1">
<title><![CDATA[Pneumatocoele in a neonate with perinatal tuberculosis]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301672v1?rss=1</link>
<description><![CDATA[<p>Pneumatocoele, a rare complication of cavitary pulmonary tuberculosis (TB), had not been reported previously in neonates. We report here a premature infant of 28 weeks gestation weighing 1150 g who had pneumatocoele following pulmonary TB infection. He was diagnosed to have TB pneumonia at 2 weeks of age (<cross-ref type="fig" refid="F1">figure 1A</cross-ref>) when acid fast bacilli were isolated from his tracheal aspirate. Tracheal aspirate culture and polymerase chain reaction for <I>Mycobacterium</I> were also positive. He made a speedy recovery following treatment with isoniazid, rifampicin and pyrazinamide. Two weeks after treatment, a large pneumatocoele developed in the right lung (<cross-ref type="fig" refid="F1">figure 1B</cross-ref>). Resolution of the lesion occurred 6 months later (figure 1C). Throughout this period, he remained well and continued to gain weight. After completing 1 year of TB treatment, his growth and development was appropriate for his age.</p><p>Matsaniotis <I>et al</I> reported five children of age between 3 months and...]]></description>
<dc:creator><![CDATA[Rohana, J., Lau, D. S. C., Hasniah, A. L., Faizah, M. Z., Boo, N.-Y., Shareena, I.]]></dc:creator>
<dc:date>2012-05-11T02:01:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301672</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301672</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Drugs: infectious diseases, Pneumonia (infectious disease), TB and other respiratory infections, Child health, Infant health, Neonatal health, Radiology, Pneumonia (respiratory medicine), Tuberculosis, Clinical diagnostic tests, Radiology (diagnostics), Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Pneumatocoele in a neonate with perinatal tuberculosis]]></dc:title>
<prism:publicationDate>2012-05-11</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301695v1?rss=1">
<title><![CDATA[Respiratory distress in a preterm baby]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301695v1?rss=1</link>
<description><![CDATA[<p>A 30-week preterm baby born by emergency caesarean section because of placenta praevia and antepartum haemorrhage was ventilated from birth and had repeated reintubations. By day 7 ventilation became difficult and on day 12 was transferred to a tertiary centre for escalation of ventilatory support. The transfer diagnosis was sepsis and pulmonary hypertension. Review of the chest x-rays (<cross-ref type="fig" refid="F1">figures 1</cross-ref> and <cross-ref type="fig" refid="F2">2</cross-ref>) shows pneumomediastinum not seen on previous x-ray, likely iatrogenic perforation of the trachea or bronchi. During echocardiogram showing marked compression of the left atrium she became bradycardic, desaturated and resuscitation was started. Discussions with cardiologists, cardiothoracic surgeons and anaesthetists decided risk of tracheal surgery too high and the patient too small to cannulate for extracorporeal support. Parents understood futility of the situation and intensive therapy was stopped. Postmortem examination reported perforation of the right main bronchus.</p><p>Tracheal perforation is a known but rare and severe...]]></description>
<dc:creator><![CDATA[Turcu, S., Mok, Q.]]></dc:creator>
<dc:date>2012-05-06T02:02:35-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301695</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301695</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Surgery, Journalology, Epidemiologic studies, Echocardiography, Hypertension, Pregnancy, Child health, Neonatal and paediatric intensive care, Neonatal health, Radiology, Surgical diagnostic tests, Clinical diagnostic tests, Radiology (diagnostics), Competing interests (ethics), Resuscitation]]></dc:subject>
<dc:title><![CDATA[Respiratory distress in a preterm baby]]></dc:title>
<prism:publicationDate>2012-05-06</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301373v1?rss=1">
<title><![CDATA[Gut microbial colonisation in premature neonates predicts neonatal sepsis]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301373v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Neonatal sepsis due to intestinal bacterial translocation is a major cause of morbidity and mortality. Understanding microbial colonisation of the gut in prematurity may predict risk of sepsis to guide future strategies to manipulate the microbiome.</p></sec><sec><st>Methods</st><p>Prospective longitudinal study of premature infants. Stool samples were obtained weekly. DNA was extracted and the V6 hypervariable region of <I>16S rRNA</I> was amplified followed by high throughput pyrosequencing, comparing subjects with and without sepsis.</p></sec><sec><st>Results</st><p>Six neonates were 24&ndash;27 weeks gestation at birth and had 18 samples analysed. Two subjects had no sepsis during the study period, two developed late-onset culture-positive sepsis and two had culture-negative systemic inflammation. 324 350 sequences were obtained. The meconium was not sterile and had predominance of <I>Lactobacillus, Staphylococcus</I> and Enterobacteriales. Overall, infants who developed sepsis began life with low microbial diversity, and acquired a predominance of <I>Staphylococcus</I>, while healthy infants had more diversity and predominance of <I>Clostridium, Klebsiella</I> and <I>Veillonella</I>.</p></sec><sec><st>Conclusions</st><p>In very low birth weight infants, the authors found that meconium is not sterile and is less diverse from birth in infants who will develop late-onset sepsis. Empiric, prolonged antibiotics profoundly decrease microbial diversity and promote a microbiota that is associated not only with neonatal sepsis, but the predominant pathogen previously identified in the microbiome. Our data suggest that there may be a &lsquo;healthy microbiome&rsquo; present in extremely premature neonates that may ameliorate risk of sepsis. More research is needed to determine whether altered antibiotics, probiotics or other novel therapies can re-establish a healthy microbiome in neonates.</p></sec>]]></description>
<dc:creator><![CDATA[Madan, J. C., Salari, R. C., Saxena, D., Davidson, L., O'Toole, G. A., Moore, J. H., Sogin, M. L., Foster, J. A., Edwards, W. H., Palumbo, P., Hibberd, P. L.]]></dc:creator>
<dc:date>2012-05-06T02:02:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301373</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301373</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Immunology (including allergy), Drugs: infectious diseases, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Gut microbial colonisation in premature neonates predicts neonatal sepsis]]></dc:title>
<prism:publicationDate>2012-05-06</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301589v1?rss=1">
<title><![CDATA[Natural history of fetal trisomy 18 after prenatal diagnosis]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301589v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To evaluate the natural fetal and neonatal outcome for pregnancies with an established prenatal diagnosis of fetal trisomy 18, and a parental decision for continuation of the pregnancy.</p></sec><sec><st>Methods</st><p>The obstetric and neonatal outcome data for 23 such pregnancies, diagnosed at a single referral Fetal Medicine Centre, were retrospectively obtained.</p></sec><sec><st>Results</st><p>The overall intrauterine fetal death rate was 61%, with a progressive decline in live fetuses up to 39 weeks gestation. For fetuses diagnosed before 20 weeks gestation, there was a trend towards a higher intrauterine fetal death rate (88%), in comparison to those diagnosed after this period (44%) (p=0.06). For live births, the preterm delivery rate was 44%. All infants born alive died within 48 h of birth.</p></sec><sec><st>Conclusion</st><p>These data provide reliable information for parental counselling pertaining to risk of intrauterine death when trisomy 18 is diagnosed prenatally. These findings suggest that long-term survival implications for trisomy 18 are different when it is diagnosed prenatally.</p></sec>]]></description>
<dc:creator><![CDATA[Burke, A. L., Field, K., Morrison, J. J.]]></dc:creator>
<dc:date>2012-05-06T02:02:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301589</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301589</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Pregnancy, Reproductive medicine]]></dc:subject>
<dc:title><![CDATA[Natural history of fetal trisomy 18 after prenatal diagnosis]]></dc:title>
<prism:publicationDate>2012-05-06</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301142v1?rss=1">
<title><![CDATA[The preterm infant with thrombosis]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301142v1?rss=1</link>
<description><![CDATA[<p>In paediatrics, sick preterm infants are at highest risk of developing thrombotic complications. Haemostasis is in a fine balance in the neonatal period, despite age-related differences in coagulation proteins. However, both inherited and acquired risk factors can disrupt this balance and can lead to thrombosis. Important risk factors are sepsis, asphyxia, dehydration, central venous lines and inherited and acquired thrombophilia. Among various treatment modalities, anticoagulation is primarily used in the management of thrombosis. Different agents, dosages and durations of treatment in this age group are extrapolated from adult data. The article reviews the epidemiology, pathophysiology, risk factors, diagnosis and treatment of thrombotic disorders in preterm infants.</p>]]></description>
<dc:creator><![CDATA[Bhat, R., Monagle, P.]]></dc:creator>
<dc:date>2012-05-06T02:02:34-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301142</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301142</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The preterm infant with thrombosis]]></dc:title>
<prism:publicationDate>2012-05-06</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301965v1?rss=1">
<title><![CDATA[Seen but not heard: congenital cytomegalovirus]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301965v1?rss=1</link>
<description><![CDATA[<p>In their important recent article, Townsend and colleagues conclude that the number of confirmed congenital cytomegalovirus (CMV) diagnoses is lower than expected.<cross-ref type="bib" refid="R1">1</cross-ref> This is unsurprising as only 5%&ndash;10% of infected children are symptomatic at birth.<cross-ref type="bib" refid="R2">2</cross-ref> However, a further 10%&ndash;15% of infected infants will develop long-term sequelae, despite being asymptomatic and therefore undiagnosed at birth.<cross-ref type="bib" refid="R3">3</cross-ref> We report an Irish experience.</p><p>We calculated the incidence and reviewed the outcomes of symptomatic cCMV in babies born between December 2004 and September 2007 in the National Maternity Hospital Dublin. The National Virus Reference Laboratory retrospectively identified babies who tested positive for CMV during the study period. Congenital infection was defined as a positive CMV culture, DEAFF test, or PCR from urine or the presence of CMV-specific IgM in blood in the first 3 weeks of life.<cross-ref type="bib" refid="R4">4</cross-ref></p><p>19 521 babies were delivered during the study period: 11 infants were...]]></description>
<dc:creator><![CDATA[Harrison, G., Waters, A., De Gascun, C. F., Boyle, M., Knowles, S., Molloy, E. J.]]></dc:creator>
<dc:date>2012-05-03T02:02:01-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301965</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301965</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Seen but not heard: congenital cytomegalovirus]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301257v1?rss=1">
<title><![CDATA[An unusual acute abdominal swelling in a preterm baby with perforated necrotising enterocolitis]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301257v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Case History</st><p>A 24-week gestation baby was managed conservatively at 23 days of life for necrotising enterocolitis (NEC) (Bell's stage 1). On day 3 of treatment, she developed an acute, localised, anterior abdominal wall swelling just to the right of the midline (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Her clinical condition had not worsened. This swelling was soft and easily reducible. We suspected that the bowel had herniated through a defect in the abdominal musculature. A lateral shoot-through abdominal x-ray suggested possible bowel herniation (<cross-ref type="fig" refid="F2">figure 2</cross-ref>). She was immediately referred to the paediatric surgeon and underwent laparotomy.</p><p>At surgery, she was found to have a perforation and necrosis of the terminal ileum from NEC. There was an intra-abdominal abscess which had eroded through the anterior abdominal wall and resulted in a collection of intra-abdominal free air subcutaneously. The patient had a burst abdomen 3 days postoperatively which was managed by wound...]]></description>
<dc:creator><![CDATA[Podugu, L., Singh, M., Rasiah, S. V.]]></dc:creator>
<dc:date>2012-05-03T02:02:31-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301257</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301257</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Competing interests (ethics), Trauma]]></dc:subject>
<dc:title><![CDATA[An unusual acute abdominal swelling in a preterm baby with perforated necrotising enterocolitis]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301340v1?rss=1">
<title><![CDATA[Variability of respiratory parameters and extubation readiness in ventilated neonates]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301340v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>A spontaneous breathing trial (SBT) has been used to guide suitability of extubation in VLBW infants. Respiratory variability (RV) has been used to assess extubation readiness in adults but was never investigated in preterms. The combination of a SBT and RV may further improve prediction of successful extubation.</p></sec><sec><st>Study design</st><p>Using data previously collected during the SBT, the following respiratory variables were analysed: inspiratory time (T<SUB>I</SUB>), expiratory time (T<SUB>E</SUB>), T<SUB>I</SUB>/total breath time, tidal volume (V<SUB>T</SUB>) and mean inspiratory flow (V<SUB>T</SUB>/T<SUB>I</SUB>). RV was quantified using time-domain analysis for each respiratory variable and expressed as a variability index (VI). The sensitivity, specificity, positive and negative predictive values (PPV and NPV) of the SBT, each VI and combined SBT+VI were calculated. Extubation failure was defined as need of re-intubation within 72 h.</p></sec><sec><st>Results</st><p>A total of 44 infants were included. Successfully (n=36) and unsuccessfully (n=8) extubated infants had similar baseline characteristics and number of breaths analysed. VI for V<SUB>T</SUB>/T<SUB>I</SUB> was significantly decreased in the failure group. The combination of the SBT and VI of either T<SUB>I</SUB> or V<SUB>T</SUB> were the most accurate predictors of successful extubation with a sensitivity of 100% and specificity of 75% and a PPV and NPV for extubation success of 95% and 100%, respectively.</p></sec><sec><st>Conclusions</st><p>A significant decrease in V<SUB>T</SUB>/T<SUB>I</SUB> variability occurred in infants requiring re-intubation. The combination of a SBT failure and decreased variability in T<SUB>I</SUB> or V<SUB>T</SUB> was highly predictive of failure. This combination is promising but requires prospective evaluation in a larger population.</p></sec>]]></description>
<dc:creator><![CDATA[Kaczmarek, J., Kamlin, C. O. F., Morley, C. J., Davis, P. G., Sant'Anna, G. M.]]></dc:creator>
<dc:date>2012-05-03T02:02:02-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301340</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301340</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Airway biology]]></dc:subject>
<dc:title><![CDATA[Variability of respiratory parameters and extubation readiness in ventilated neonates]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301276v1?rss=1">
<title><![CDATA[Seasonal variations in healthcare-associated infection in neonates in Canada]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301276v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To assess the seasonal pattern of healthcare-associated infections (HCAI) among neonates and to describe the trend of HCAI.</p></sec><sec><st>Design</st><p>Secondary analyses of database.</p></sec><sec><st>Setting</st><p>The Canadian Neonatal Network database (2003&ndash;2009).</p></sec><sec><st>Participants</st><p>Neonates with HCAI defined as blood/cerebrospinal fluid positive with pathogenic organism in a symptomatic infant after 2 days of age.</p></sec><sec><st>Main outcome measure</st><p>The incidence rate for HCAI per 1000 days with a 95% CI, for the 4 warmest months (June&ndash;September) was compared with the remaining 8 months, to calculate the incidence rate ratio (IRR).</p></sec><sec><st>Results</st><p>Of 75 629 total infants, 4305 (5.7%) had HCAI (3367 had 1 and 938 had &gt;1 episodes). Infants who had HCAI were of lower gestation, birth weight and Apgar score; but had higher severity of illness scores and clinical chorioamnionitis. There was a borderline increase in all HCAI (IRR 1.05, 95% CI 1.00 to 1.11) and a significant increase in Gram-negative HCAI (IRR 1.20, 95% CI 1.04 to 1.39) during the summer months. Overall, there was a 20% reduction in HCAI from 4.45/1000 days in January 2003 to 3.54/1000 days in December 2009 (mean difference 0.91/1000 days (95% CI 0.89 to 0.92).</p></sec><sec><st>Conclusions</st><p>Gram-negative infections were significantly increased during the summer months of the year compared with the rest of the year among neonates. Overall, there was a significant temporal reduction in HCAI rates over the study period.</p></sec>]]></description>
<dc:creator><![CDATA[Shah, P. S., Yoon, W., Kalapesi, Z., Bassil, K., Dunn, M., Lee, S. K.]]></dc:creator>
<dc:date>2012-05-03T02:02:02-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301276</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301276</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Pregnancy, Child health]]></dc:subject>
<dc:title><![CDATA[Seasonal variations in healthcare-associated infection in neonates in Canada]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300435v1?rss=1">
<title><![CDATA[Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300435v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>A randomised, double-blind clinical trial was undertaken in order to assess the effectiveness of probiotics in the prevention of necrotising enterocolitis (NEC) in newborns weighing &lt;1500 g.</p></sec><sec><st>Methods</st><p>We studied a group of 150 patients who were randomised in two groups after parental consent was obtained, to receive either a daily feeding supplementation with a multispecies probiotic (<I>Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus casei, Lactobacillus plantarum, Bifidobacteruim infantis, Streptococcus thermophillus</I>) 1 g per day plus their regular feedings or to receive their regular feedings with nothing added (control group), over the period of January 2007 through June 2010. Clinicians in care of the infants were blinded to the group assignment.</p></sec><sec><st>Results</st><p>The primary outcome was the development of NEC. Both groups were comparable, with no differences during hospitalisation, including the type of nutrition received. Blood cultures obtained from cases that developed sepsis did not reveal lactobacillus or Bifidobacteria growth. No differences were detected in terms of NEC risk reduction (RR: 0.54, 95% CI 0.21 to 1.39) although we did observe a clear trend in the reduction of NEC frequency in the studied cases: 6 (8%) versus 12 (16%) in the control group. When the combined risk of NEC or death was calculated as a post hoc analysis, we found a significantly lower risk (RR: 0.39, 95% CI 0.17 to 0.87) for the study group.</p></sec><sec><st>Conclusions</st><p>Probiotics may offer potential benefits for premature infants and are a promising strategy in the reduction of the risk of NEC in preterm newborns.</p></sec>]]></description>
<dc:creator><![CDATA[Fernandez-Carrocera, L. A., Solis-Herrera, A., Cabanillas-Ayon, M., Gallardo-Sarmiento, R. B., Garcia-Perez, C. S., Montano-Rodriguez, R., Echaniz-Aviles, M. O. L.]]></dc:creator>
<dc:date>2012-05-03T02:02:31-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300435</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300435</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Childhood nutrition, Childhood nutrition (paediatrics), Child health, Infant health, Infant nutrition (including breastfeeding), Neonatal health]]></dc:subject>
<dc:title><![CDATA[Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301066v1?rss=1">
<title><![CDATA[Axillary temperature measurement during hypothermia treatment for neonatal hypoxic-ischaemic encephalopathy]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301066v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To determine the accuracy of axillary temperature relative to core rectal temperature during whole-body therapeutic hypothermia for moderate-to-severe hypoxic-ischaemic encephalopathy.</p></sec><sec><st>Design</st><p>Retrospective audit.</p></sec><sec><st>Setting</st><p>Single tertiary neonatal intensive care unit at The Royal Women's Hospital in Australia.</p></sec><sec><st>Patients</st><p>Fifty-eight term newborn infants with moderate-to-severe hypoxic-ischaemic encephalopathy. Forty infants were treated with whole-body hypothermia between February 2001 and May 2010, 16 of whom were enrolled in the Infant Cooling Evaluation (ICE) trial, and 18 control infants randomised to normothermia in the ICE trial.</p></sec><sec><st>Intervention</st><p>Comparison of simultaneous axillary and rectal temperatures measured between 0 and 84 h post randomisation or induction of cooling.</p></sec><sec><st>Results</st><p>During the initiation of hypothermia (0&ndash;&lt;6 h) axillary and rectal temperatures were similar (mean difference rectal-axillary =0.07&deg;C), but with large variability (95% limits of agreement &ndash;1.18 to 1.33&deg;C). There was larger variability in measurements between 6 and &lt;72 h in the hypothermic infants (total SD 0.44) than in the normothermic group (total SD 0.24, p&lt;0.001). In the hypothermic infants, the mean difference between the measurements during the rewarming phase (72&ndash;&lt;84 h) was &ndash;0.19&deg;C (95% limits of agreement &ndash;0.95 to 0.57&deg;C).</p></sec><sec><st>Conclusion</st><p>As there is wide variability in the difference between axillary and rectal temperatures at all stages of whole-body cooling, our data do not support the use of axillary temperature as a surrogate for core rectal temperature during therapeutic hypothermia.</p></sec>]]></description>
<dc:creator><![CDATA[Landry, M.-A., Doyle, L. W., Lee, K., Jacobs, S. E.]]></dc:creator>
<dc:date>2012-05-03T02:02:30-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301066</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301066</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Axillary temperature measurement during hypothermia treatment for neonatal hypoxic-ischaemic encephalopathy]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301025v1?rss=1">
<title><![CDATA[Osteopenia in preterm infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301025v1?rss=1</link>
<description><![CDATA[<p>In the newborn preterm infant a combination of inadequate reserves and increased loss of essential minerals is common and frequently compounded by difficulties in obtaining an intake sufficient to replace losses and restore reserves. Deficiencies in calcium and phosphate and disturbed balance between them are frequently encountered, and may lead to significant impairment of bone deposition. Osteopenia of prematurity &ndash; also known as neonatal rickets, rickets of prematurity or neonatal metabolic bone disease &ndash; is a common and important concern in neonatology, and effective management is hindered by difficulties in accurately assessing calcium and phosphate status and the &lsquo;quality&rsquo; of bone deposition.</p><p>It is well known that preterm infants are at risk of reduced bone mineral content (BMC) and subsequent bone disease and that many factors may contribute to this. The majority of calcium and phosphate accretion and bone mineralisation occur in the third trimester of pregnancy and from 24 weeks...]]></description>
<dc:creator><![CDATA[Harrison, C. M., Gibson, A. T.]]></dc:creator>
<dc:date>2012-05-03T02:02:02-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301025</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301025</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Osteopenia in preterm infants]]></dc:title>
<prism:publicationDate>2012-05-03</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301470v1?rss=1">
<title><![CDATA[A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301470v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>The authors performed a randomised trial in very preterm small-for-gestational age (SGA) babies to determine if prophylaxis with granulocyte-macrophage colony-stimulating factor (GM-CSF) improves outcomes (the PROGRAMS trial). Despite increased neutrophil counts following GM-CSF, the authors reported no significant difference in neonatal sepsis-free survival.</p></sec><sec><st>Patients and methods</st><p>280 babies born &lt;31 weeks of gestation and SGA were entered into the trial. Outcome was determined at 2 years to determine neurodevelopmental and general health outcomes, including economic costs.</p></sec><sec><st>Results</st><p>The authors found no significant differences in health outcomes or health and social care costs between the trial groups. In the GM-CSF arm, 87 of 134 (65%) babies survived to 2 years without severe disability compared with 87 of 131 (66%) controls (RR: 1&middot;0, 95% CI 0&middot;8 to 1&middot;2). Marginally, more children receiving GM-CSF were reported to have cough (RR 1&middot;7, 95% CI 1&middot;1 to 2&middot;6) and had signs of chronic respiratory disease (Harrison's sulcus; RR 2&middot;0, 95% CI 1&middot;0 to 3&middot;9) though this was not reflected in bronchodilator use or need for hospitalisation for respiratory disease. Overall, the rate of neurologic abnormality (7%&ndash;9%) was similar but mean overall developmental scores were lower than expected for gestational age.</p></sec><sec><st>Conclusions</st><p>The administration of GM-CSF to very preterm SGA babies is not associated with improved or more adverse outcomes at 2 years of age. The apparent excess of developmental impairment in the entire PROGRAMS cohort, without corresponding increase in neurological abnormality, may represent diffuse brain injury attributable to intrauterine growth restriction.</p></sec>]]></description>
<dc:creator><![CDATA[Marlow, N., Morris, T., Brocklehurst, P., Carr, R., Cowan, F. M., Patel, N., Petrou, S., Redshaw, M. E., Modi, N., Dore, C.]]></dc:creator>
<dc:date>2012-04-27T02:01:22-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301470</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301470</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Unlocked, Immunology (including allergy), Neurological injury, Child health, Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[A randomised trial of granulocyte-macrophage colony-stimulating factor for neonatal sepsis: outcomes at 2 years]]></dc:title>
<prism:publicationDate>2012-04-27</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300539v1?rss=1">
<title><![CDATA[The defecation pattern of healthy term infants up to the age of 3 months]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300539v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Defecation problems occur frequently in infants. A clearer insight into the normal defecation pattern is required to gain a better understanding of abnormal defecation.</p></sec><sec><st>Aim</st><p>To describe the defecation pattern of healthy infants in The Netherlands.</p></sec><sec><st>Methods</st><p>From a research population of 1175 healthy Dutch infants, 600 infants without any complaints were selected. The parents recorded details of feeding and defecation at the age of 1, 2 and 3 months using a standardised questionnaire and bowel diary.</p></sec><sec><st>Results</st><p>In breastfed infants, average daily defecation frequency decreased significantly during the first 3 months (from 3.65 to 1.88 times per day), whereas no significant changes were observed in infants fed standard formula or mixed feeding. At every age both the average and the range of defecation frequency of breastfed infants were higher than those of infants receiving formula feeding. Breastfed infants had softer faeces than formula-fed infants and the colour more often was yellow. At the age of 3 months, 50% of stools of formula-fed infants were green coloured. There was no significant difference in quantity between the three types of feeding, but there existed a negative correlation between defecation frequency and quantity.</p></sec><sec><st>Conclusion</st><p>This study gives insight into the defecation patterns of the largest cohort of healthy infants published so far. In the first 3 months of life, breastfed infants have more frequent, softer and more yellow-coloured stools than standard formula-fed infants. Green-coloured stools in standard formula-fed infants should be considered normal.</p></sec>]]></description>
<dc:creator><![CDATA[den Hertog, J., van Leengoed, E., Kolk, F., van den Broek, L., Kramer, E., Bakker, E.-J., Gijssel, E. B.-v., Bulk, A., Kneepkens, F., Benninga, M. A.]]></dc:creator>
<dc:date>2012-04-20T02:01:31-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300539</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300539</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Childhood nutrition, Reproductive medicine, Infant nutrition (including breastfeeding)]]></dc:subject>
<dc:title><![CDATA[The defecation pattern of healthy term infants up to the age of 3 months]]></dc:title>
<prism:publicationDate>2012-04-20</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301572v1?rss=1">
<title><![CDATA[Babies born at the threshold of viability: changes in survival and workload over 20 years]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301572v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To assess the care given to the babies born at the threshold of viability over the last 20 years using regional and national data.</p></sec><sec><st>Design</st><p>Population-based retrospective study.</p></sec><sec><st>Setting</st><p>Former &lsquo;Trent&rsquo; health region.</p></sec><sec><st>Participants</st><p>Babies born between 1 January 1991 and 31 December 2010 at 22<sup>+0</sup> to 25<sup>+6</sup> weeks gestational age.</p></sec><sec><st>Main outcome measure</st><p>Survival and use of respiratory support.</p></sec><sec><st>Methods</st><p>Data of all babies born between 1 January 1991 and 31 December 2010 with a gestational age of 22<sup>+0</sup> to 25<sup>+6</sup> weeks and admitted to a neonatal unit were extracted from The Neonatal Survey. Use of respiratory support in terms of ventilation and continuous positive airway pressure (CPAP) for this group of babies was calculated as a proportion of the total used by the whole neonatal intensive care population within the defined study area.</p></sec><sec><st>Results</st><p>The proportion of babies surviving to discharge increased significantly over time in those born at 24 and 25 weeks (p&lt;0.01) but failed to achieve statistical significance for those at 23 weeks (p=0.08). No babies born at 22 weeks survived. The babies born at 22&ndash;25 weeks accounted for 26.3% of all ventilation and 21.5% of CPAP given.</p></sec><sec><st>Conclusion</st><p>Our work concurs with the current UK guidelines. There could be advantages in focusing the care of babies born at 23 weeks to a small number of intensive care units to allow specialist expertise to develop in all aspects of the management of these babies. However, focusing care will not necessarily improve survival or reduce morbidity.</p></sec>]]></description>
<dc:creator><![CDATA[Seaton, S. E., King, S., Manktelow, B. N., Draper, E. S., Field, D. J.]]></dc:creator>
<dc:date>2012-04-19T02:01:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301572</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301572</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Unlocked, Child health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Babies born at the threshold of viability: changes in survival and workload over 20 years]]></dc:title>
<prism:publicationDate>2012-04-19</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300974v1?rss=1">
<title><![CDATA[Randomised weaning trial comparing assist control to pressure support ventilation]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300974v1?rss=1</link>
<description><![CDATA[<sec><st>Objectives</st><p>To determine if the work of breathing was lower, respiratory muscle strength greater, but the degree of asynchrony higher during weaning by assist control ventilation (ACV) rather than pressure support ventilation (PSV) and if any differences were associated with a shorter duration of weaning.</p></sec><sec><st>Design</st><p>Randomised trial</p></sec><sec><st>Setting</st><p>Tertiary neonatal unit</p></sec><sec><st>Patients</st><p>Thirty-six infants, median gestational age 29 (range 24 to 39) weeks</p></sec><sec><st>Intervention</st><p>Weaning by either ACV or PSV.</p></sec><sec><st>Main outcome measures</st><p>At baseline, 24 hours after entering the study and immediately prior to extubation, the work of breathing (PTPdi), thoracoabdominal asynchrony (TAA) and respiratory muscle strength (Pimax) were assessed and weaning duration recorded.</p></sec><sec><st>Results</st><p>There were no significant differences in the median PTPdi, TAA and Pimax results at any time point. The inflation times during ACV and PSV were similar. The median duration of weaning was 34 (range 7&ndash;100) hours in the ACV group and 27 (range 10&ndash;169) hours in the PSV group (p=0.88).</p></sec><sec><st>Conclusion</st><p>No significant differences were found between weaning by PSV and ACV when similar inflation times were used.</p></sec>]]></description>
<dc:creator><![CDATA[Shefali-Patel, D., Murthy, V., Hannam, S., Lee, S., Rafferty, G. F., Greenough, A.]]></dc:creator>
<dc:date>2012-04-19T02:01:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300974</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300974</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Childhood nutrition, Airway biology]]></dc:subject>
<dc:title><![CDATA[Randomised weaning trial comparing assist control to pressure support ventilation]]></dc:title>
<prism:publicationDate>2012-04-19</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301218v1?rss=1">
<title><![CDATA[Early lactation failure and formula adoption after elective caesarean delivery: cohort study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301218v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To investigate the effects of elective primary and elective repeat caesarean deliveries on lactation at hospital discharge.</p></sec><sec><st>Design</st><p>Cohort study.</p></sec><sec><st>Setting</st><p>Four Italian teaching hospitals &ndash; Padua, Brescia, L'Aquila and Udine.</p></sec><sec><st>Interventions</st><p>Deliveries were classified as vaginal, elective caesarean (primary and repeat) or emergency caesarean. A total of 2296 (24.7%) infants born by caesarean section (CS), 816 of which (35.5%) classified as primary elective CS and 796 (34.7%) as repeat elective CS, were studied. Moreover, 30.2% of the elective CS deliveries took place before 39 weeks.</p></sec><sec><st>Main outcome measures</st><p>Feeding modalities at discharge: formula, complementary and breastfeeding.</p></sec><sec><st>Results</st><p>At discharge, 6.9% of the vaginal delivery mothers, 8.3% of the emergency CS mothers, 18.6% of the elective CS mothers, 23.3% of the primary CS mothers and 13.9% of the repeat CS mothers were using infant formula exclusively. Multivariate analysis (OR; 95% CI) identified primary elective delivery (3.74; 3.0 to 4.60), lower gestational age (1.16; 1.10 to 1.23), and place L'Aquila versus Udine (1.42; 1.01 to 2.09) and of Brescia versus Udine hospitals (6.16; 4.53 to 8.37) as independent predictors of formula feeding at discharge.</p></sec><sec><st>Conclusions</st><p>These findings provide new information about the risks of breastfeeding failure connected to elective CS delivery, particularly if primary and scheduled before 39 weeks of gestation.</p></sec>]]></description>
<dc:creator><![CDATA[Zanardo, V., Pigozzo, A., Wainer, G., Marchesoni, D., Gasparoni, A., Di Fabio, S., Cavallin, F., Giustardi, A., Trevisanuto, D.]]></dc:creator>
<dc:date>2012-04-19T02:01:48-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301218</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301218</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Childhood nutrition, Reproductive medicine, Infant nutrition (including breastfeeding)]]></dc:subject>
<dc:title><![CDATA[Early lactation failure and formula adoption after elective caesarean delivery: cohort study]]></dc:title>
<prism:publicationDate>2012-04-19</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301702v1?rss=1">
<title><![CDATA[Multiple brain abscesses and facial palsy in a neonate]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301702v1?rss=1</link>
<description><![CDATA[<p>A term, 3.5-kg male neonate was referred to our hospital on day 5 of life for respiratory distress, hypoglycaemia and feed intolerance. There was no history of perinatal asphyxia or birth trauma. Investigations revealed thrombocytopaenia and coagulopathy with raised C reactive protein and leucocytosis. Chest x-ray was suggestive of pneumonia. He was started on Vancomycin and Piperacillin-Tazobactum for suspected sepsis. His blood culture grew <I>Klebsiella pneumoniae</I>, sensitive to Imipenem. Cerebrospinal fluid (CSF) examination was normal. On day 10 of life, he was noted to have right-sided lower motor neuron type facial palsy (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Rest of the neurological examination was unremarkable. Ultrasonography of brain revealed few hyperechoic lesions in the right basal ganglia and bilateral frontal regions. For a better delineation of these lesions, a MRI of brain was done, which revealed multiple small ring-enhancing lesions in bilateral frontal and parietal lobes, right basal ganglia and right pons....]]></description>
<dc:creator><![CDATA[Louis, D., Balasubramanian, K., Sundaram, V.]]></dc:creator>
<dc:date>2012-04-13T02:01:30-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301702</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301702</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Drugs: infectious diseases, Meningitis, Pneumonia (infectious disease), TB and other respiratory infections, Infection (neurology), Radiology, Pneumonia (respiratory medicine), Dentistry and oral medicine, Clinical diagnostic tests, Radiology (diagnostics), Competing interests (ethics), Trauma, Diabetes, Metabolic disorders, Injury]]></dc:subject>
<dc:title><![CDATA[Multiple brain abscesses and facial palsy in a neonate]]></dc:title>
<prism:publicationDate>2012-04-13</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-300989v1?rss=1">
<title><![CDATA[The effect of a multifaceted educational intervention on medication preparation and administration errors in neonatal intensive care]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-300989v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To examine the effect of a multifaceted educational intervention on the incidence of medication preparation and administration errors in a neonatal intensive care unit (NICU).</p></sec><sec><st>Design</st><p>Prospective study with a preintervention and postintervention measurement using direct observation.</p></sec><sec><st>Setting</st><p>NICU in a tertiary hospital in the Netherlands.</p></sec><sec><st>Intervention</st><p>A multifaceted educational intervention including teaching and self-study.</p></sec><sec><st>Main outcome measures</st><p>The incidence of medication preparation and administration errors. Clinical importance was assessed by three experts.</p></sec><sec><st>Results</st><p>The incidence of errors decreased from 49% (43&ndash;54%) (151 medications with one or more errors of 311 observations) to 31% (87 of 284) (25&ndash;36%). Preintervention, 0.3% (0&ndash;2%) medications contained severe errors, 26% (21&ndash;31%) moderate and 23% (18&ndash;28%) minor errors; postintervention, none 0% (0&ndash;2%) was severe, 23% (18&ndash;28%) moderate and 8% (5&ndash;12%) minor. A generalised estimating equations analysis provided an OR of 0.49 (0.29&ndash;0.84) for period (p=0.032), (route of administration (p=0.001), observer within period (p=0.036)).</p></sec><sec><st>Conclusions</st><p>The multifaceted educational intervention seemed to have contributed to a significant reduction of the preparation and administration error rate, but other measures are needed to improve medication safety further.</p></sec>]]></description>
<dc:creator><![CDATA[Chedoe, I., Molendijk, H., Hospes, W., Van den Heuvel, E. R., Taxis, K.]]></dc:creator>
<dc:date>2012-04-05T02:01:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-300989</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-300989</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[The effect of a multifaceted educational intervention on medication preparation and administration errors in neonatal intensive care]]></dc:title>
<prism:publicationDate>2012-04-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301334v1?rss=1">
<title><![CDATA[The 3:1 is superior to a 15:2 ratio in a newborn manikin model in terms of quality of chest compressions and number of ventilations]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301334v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Most cases of delivery room cardiopulmonary arrest result from an asphyxial process. Experimental evidence supports an important role for ventilation during asphyxial arrest. The optimal compression: ventilation (CV) ratio remains unclear and recommendations for newborns have varied from 3:1, 5:1 and 15:2.</p></sec><sec><st>Objective</st><p>Compare 3:1, 5:1 and 15: 2 CV ratios using the two-thumb technique in relationship to depth of compressions, decay of compression depth over time, compression rates and breaths delivered.</p></sec><sec><st>Methods</st><p>Thirty-two subjects, physicians and neonatal nurses, participated with compressions performed on a manikin. Evaluations included 2 min of compressions using 3:1, 5:1 and 15:2 CV ratios.</p></sec><sec><st>Results</st><p>Compression depth was comparable between groups. By paired analysis per subject, the depth was only greater for 3:1 versus 15:2 (ie, 0.91&plusmn;2.2 mm) (p=0.01) and greater for women than men. Comparing the initial and second minute of compressions, no decay in compression depth for 3:1 ratio was noted, however significant decay was observed for 5:1 and 15:2 ratios (p&lt;0.05). The compression rates were least and ventilations breaths were highest for 3:1 as opposed to the other ratios (p&lt;0.05).</p></sec><sec><st>Conclusions</st><p>Providers using a 3:1 versus 15:2 achieve a greater depth of compressions over 2 min with a greater difference noted in women. More consistent compression depth over time was achieved with 3:1 as opposed to the other ratios. Thus, the 3:1 ratio is appropriate for newly born infants requiring resuscitation.</p></sec>]]></description>
<dc:creator><![CDATA[Hemway, R. J., Christman, C., Perlman, J.]]></dc:creator>
<dc:date>2012-04-03T02:00:53-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301334</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301334</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Nursing, Resuscitation]]></dc:subject>
<dc:title><![CDATA[The 3:1 is superior to a 15:2 ratio in a newborn manikin model in terms of quality of chest compressions and number of ventilations]]></dc:title>
<prism:publicationDate>2012-04-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300973v1?rss=1">
<title><![CDATA[Risk factors for perinatal arterial ischaemic stroke in full-term infants: a case-control study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300973v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>The incidence of perinatal arterial ischaemic stroke (PAIS) is about 1 in 2300 live births. Evidence about the aetiology is still lacking. The aim of this study was to identify maternal, perinatal and neonatal risk factors for symptomatic PAIS in full-term infants.</p></sec><sec><st>Methods</st><p>Each full-term infant with PAIS was matched to three healthy controls for gestational age, date of birth and hospital of birth. Antenatal and perinatal risk factors were studied using univariate and multivariate conditional logistic regression analysis.</p></sec><sec><st>Results</st><p>Fifty-two infants were diagnosed with PAIS. Significant risk factors in the univariate analysis (p&lt;0.05) were nulliparity (64% vs 47%), maternal fever (&gt;38&deg;C) during delivery (10% vs 1%), fetal heart rate decelerations (63% vs 16%), meconium-stained amniotic fluid (44% vs 17%), emergency caesarean section (35 vs 2%), Apgar score (1 min) &le;3 (29% vs 1%), Apgar score (5 min) &lt;7 (25% vs 1%), umbilical artery pH &lt;7.10 (56% vs 10%), hypoglycaemia &lt;2.0 mmol/l (29% vs 3%) and early-onset sepsis/meningitis (14% vs 2%). In the multivariate analysis, maternal fever (OR 10.2; 95% CI 1.3 to 78.5), Apgar score (5 min) &lt;7 (OR 18.1; 95% CI 3.4 to 96.8), hypoglycaemia &lt;2.0 mmol/l (OR 13.0; 95% CI 3.2 to 52.6) and early-onset sepsis/meningitis (OR 5.8; 95% CI 1.1 to 31.9) were significantly associated with PAIS.</p></sec><sec><st>Conclusions</st><p>Maternal fever during delivery and early-onset sepsis/meningitis were found to be involved with PAIS as was previously noted. Apgar score (5 min) &lt;7 and hypoglycaemia were found to be important risk factors in term PAIS.</p></sec>]]></description>
<dc:creator><![CDATA[Harteman, J. C., Groenendaal, F., Kwee, A., Welsing, P. M., Benders, M. J., de Vries, L. S.]]></dc:creator>
<dc:date>2012-03-24T02:01:08-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300973</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300973</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Stroke, Child health, Diabetes, Metabolic disorders]]></dc:subject>
<dc:title><![CDATA[Risk factors for perinatal arterial ischaemic stroke in full-term infants: a case-control study]]></dc:title>
<prism:publicationDate>2012-03-24</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301758v1?rss=1">
<title><![CDATA[Listeria monocytogenes: generalised maculopapular rash may be the clue]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301758v1?rss=1</link>
<description><![CDATA[<p>Early-onset sepsis is an important cause of morbidity and mortality among newborn infants and one of the causative organisms can be <I>Listeria monocytogenes.</I> Occasionally, it may be suspected from physical findings. This 1996 g female infant was born at 33 weeks gestation by caesarean section for premature labour with chorioamnionitis and fetal distress. She responded to resuscitation with Apgar scores of 6 and 7 at 1 and 5 min, respectively. She was admitted to the Neonatal Intensive Care Unit where she required ventilation. Physical examination revealed a generalised maculopapular rash, respiratory distress and abdominal distension with hepatomegaly. Owing to the suspicion of <I>L monocytogenes</I> infection, she was treated with high-dose intravenous ampicillin, gentamicin and cefotaxime. She needed fluid resuscitation, high-dose pressors, steroids, blood component transfusions and nitric oxide for septic shock. Maternal intrapartum antibiotics had been administered, so blood culture was sterile. Placental and peripheral cultures (ear, conjunctival, umbilical swab...]]></description>
<dc:creator><![CDATA[Benitez-Segura, I., Fiol-Jaume, M., Balliu, P. R., Tejedor, M.]]></dc:creator>
<dc:date>2012-03-23T02:03:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301758</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301758</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Epidemiologic studies, Drugs: infectious diseases, Drugs: CNS (not psychiatric), Epilepsy and seizures, Pregnancy, Child health, Competing interests (ethics), Resuscitation]]></dc:subject>
<dc:title><![CDATA[Listeria monocytogenes: generalised maculopapular rash may be the clue]]></dc:title>
<prism:publicationDate>2012-03-23</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301658v1?rss=1">
<title><![CDATA[Withdrawal of artificial nutrition and hydration in the Neonatal Intensive Care Unit: parental perspectives]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2012-301658v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To review the experience of the practice of withdrawal of artificial nutrition and hydration (WANH) and to describe parental perspectives on the process.</p></sec><sec><st>Design</st><p>A retrospective chart review and parental survey.</p></sec><sec><st>Setting</st><p>Tertiary level Neonatal Intensive Care Unit (NICU).</p></sec><sec><st>Participants</st><p>Infants who had WANH after withdrawal of other life-sustaining treatment, and their parents.</p></sec><sec><st>Main outcome measure</st><p>Parental perspectives on the care and process were obtained through a survey administered 1 to 4 years after the death of their infant.</p></sec><sec><st>Results</st><p>Fifteen cases (5.5% of all mortality and 0.5% of all admissions) of WANH were identified, and 10 parents participated in the survey. The median (range) gestational age was 40 weeks (31&ndash;42) and birth weight was 3409 g (2000&ndash;4640). The reason for WANH was predicted poor outcome due to severe neurological injury/disease. The median (range) time between WANH and death was 16 days (2&ndash;37). All parents reported favourable perceptions of preparation, support, communication and care. Seven parents reported concerns regarding pain experienced by their infant. Parents reported the ability to spend quality time, creating tangible memories and the virtues and professional qualities of the caregivers to be helpful, but identified that consistency and continuity of care could be improved.</p></sec><sec><st>Conclusion</st><p>Within the spectrum of palliative care in neonates, WANH can be a tenable, justifiable and humane practice in the NICU.</p></sec>]]></description>
<dc:creator><![CDATA[Hellmann, J., Williams, C., Ives-Baine, L., Shah, P. S.]]></dc:creator>
<dc:date>2012-03-23T02:03:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2012-301658</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2012-301658</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Pain (neurology), Childhood nutrition, Childhood nutrition (paediatrics), Child health, Infant health, Infant nutrition (including breastfeeding), Neonatal and paediatric intensive care, Hospice, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Withdrawal of artificial nutrition and hydration in the Neonatal Intensive Care Unit: parental perspectives]]></dc:title>
<prism:publicationDate>2012-03-23</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301282v1?rss=1">
<title><![CDATA[Transfusion-associated necrotising enterocolitis in neonates]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301282v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To evaluate the association between blood transfusion in previous 2 days and necrotising enterocolitis (NEC) in infants admitted to neonatal intensive care units in Canada.</p></sec><sec><st>Patients and Methods</st><p>Using the Canadian Neonatal Network database of admissions to neonatal intensive care units from 2003 to 2008, cases with NEC were matched with controls by gestational age (GA) at birth. Exposure to transfusion within 2 days of NEC (for cases) or 2 days before the median age of NEC diagnosis among cases of the same GA (for controls) was determined. After controlling for confounders, the differences in characteristics and neonatal outcomes of transfusion-associated NEC (TANEC) and NEC not associated with transfusion (non-TANEC) were compared.</p></sec><sec><st>Results</st><p>NEC cases (n=927) were matched with 2781 controls. Transfusion in previous 2 days was significantly higher in NEC cases than in controls (15.5 vs 7.7%; adjusted OR (AOR) 2. 44; 95% CI 1.87 to 3.18). TANEC cases versus non-TANEC cases had a lower mean GA (25.8 vs 29.3 weeks), a lower mean birthweight (885 vs 1373 grams), and a higher proportion of infants with SNAPII score &gt;20 (52.1 vs 22.9%). After adjustment for confounders, no significant differences in mortality (AOR 1.28, 95% CI 0.82 to 2.01), severe retinopathy (AOR 1.15, 95% CI 0.71 to 1.87), or severe neurological injury (AOR 0.83, 95% CI 0.43 to 1.60) were identified.</p></sec><sec><st>Conclusions</st><p>Exposure to transfusion in previous 2 days was an independent risk factor for NEC. After controlling for confounders, no significant differences in mortality and morbidities were observed between infants who had transfusion-associated NEC and those with NEC not associated with transfusion.</p></sec>]]></description>
<dc:creator><![CDATA[Stritzke, A. I., Smyth, J., Synnes, A., Lee, S. K., Shah, P. S.]]></dc:creator>
<dc:date>2012-03-23T02:03:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301282</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301282</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies]]></dc:subject>
<dc:title><![CDATA[Transfusion-associated necrotising enterocolitis in neonates]]></dc:title>
<prism:publicationDate>2012-03-23</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301309v1?rss=1">
<title><![CDATA[Organ volume measurements: comparison between MRI and autopsy findings in infants following sudden unexpected death]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301309v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To assess the accuracy of a semiautomated 3D volume reconstruction method for organ volume measurement by postmortem MRI.</p></sec><sec><st>Methods</st><p>This prospective study was approved by the institutional review board and the infants' parents gave their consent. Postmortem MRI was performed in 16 infants (1 month to 1 year of age) at 1.5 T within 48 h of their sudden death. Virtual organ volumes were estimated using the Myrian software. Real volumes were recorded at autopsy by water displacement. The agreement between virtual and real volumes was quantified following the Bland and Altman's method.</p></sec><sec><st>Results</st><p>There was a good agreement between virtual and real volumes for brain (mean difference: &ndash;0.03% (&ndash;13.6 to +7.1)), liver (+8.3% (&ndash;9.6 to +26.2)) and lungs (+5.5% (&ndash;26.6 to +37.6)). For kidneys, spleen and thymus, the MRI/autopsy volume ratio was close to 1 (kidney: 0.87&plusmn;0.1; spleen: 0.99&plusmn;0.17; thymus: 0.94&plusmn;0.25), but with a less good agreement. For heart, the MRI/real volume ratio was 1.29&plusmn;0.76, possibly due to the presence of residual blood within the heart. The virtual volumes of adrenal glands were significantly underestimated (p=0.04), possibly due to their very small size during the first year of life. The percentage of interobserver and intraobserver variation was lower or equal to 10%, but for thymus (15.9% and 12.6%, respectively) and adrenal glands (69% and 25.9%).</p></sec><sec><st>Conclusions</st><p>Virtual volumetry may provide significant information concerning the macroscopic features of the main organs and help pathologists in sampling organs that are more likely to yield histological findings.</p></sec>]]></description>
<dc:creator><![CDATA[Prodhomme, O., Seguret, F., Martrille, L., Pidoux, O., Cambonie, G., Couture, A., Rouleau, C.]]></dc:creator>
<dc:date>2012-03-23T02:03:19-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301309</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301309</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Immunology (including allergy), Pathology]]></dc:subject>
<dc:title><![CDATA[Organ volume measurements: comparison between MRI and autopsy findings in infants following sudden unexpected death]]></dc:title>
<prism:publicationDate>2012-03-23</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301395v1?rss=1">
<title><![CDATA[Comparing oxygen targeting in preterm infants between the Masimo and Philips pulse oximeters]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301395v1?rss=1</link>
<description><![CDATA[<p>Randomised trials demonstrate that different approaches to oxygen saturation targeting in preterm infants significantly affect mortality.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref> The oxygen saturation algorithm used also has an effect, with decreased mortality seen when targeting higher saturations with some algorithms (13.3% vs 21.8%), but not with others (14.8% vs 15.5%).<cross-ref type="bib" refid="R2">2</cross-ref> This difference may be explained by an artefact within the Masimo SET Radical pulse oximeter which displays a reduced frequency of saturations at 87&ndash;90%.<cross-ref type="bib" refid="R3">3</cross-ref></p><p>The Philips Intellivue MP70 is a widely used monitoring system that allows saturation to be monitored using either a Masimo SatShare module or an inbuilt Philips algorithm. The aims of this study were to confirm an artefacted saturation distribution using the Masimo SatShare; to exclude similar artefact with the Philips algorithm, and to assess the suitability of the Philips algorithm for routine neonatal use.</p><p>As infants received standard care and continuous monitoring with...]]></description>
<dc:creator><![CDATA[Li, D., Jeyaprakash, V., Foreman, S., Groves, A. M.]]></dc:creator>
<dc:date>2012-03-13T02:01:38-07:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301395</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301395</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Comparing oxygen targeting in preterm infants between the Masimo and Philips pulse oximeters]]></dc:title>
<prism:publicationDate>2012-03-13</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300665v1?rss=1">
<title><![CDATA[Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300665v1?rss=1</link>
<description><![CDATA[<sec><st>Objectives</st><p>To identify infant, obstetrical and maternal characteristics associated with arterial ischaemic stroke (AIS) and venous thromboembolism (VTE) in infancy (&lt;1 year).</p></sec><sec><st>Design</st><p>Nationwide, population-based nested case-control study. All infants with a verified first-time diagnosis of AIS, VTE or both in Denmark through the years 1994&ndash;2006 were included, and 10 population controls were selected for each case.</p></sec><sec><st>Results</st><p>Case-infants presented with AIS (n=71) or VTE (n=38). AIS in infancy was associated with primiparity (adjusted OR 5.9 CI 95% 3.0 to 11.6)), delivery by an emergency caesarean section (adjusted OR 1.9 (CI 95% 1.0 to 3.3)), and post-term birth (adjusted OR 2.2 (CI 95% 1.1 to 4.8)). Male sex was associated with an increased risk of AIS among neonates (crude OR 1.8 (CI 95% 1.0 to 3.4)) but not among later born (crude OR 0.6 (CI 95% 0.2 to 1.4)). Risk factors for VTE in infancy included preterm birth (adjusted OR 5.5 (CI 95% 1.8 to 16.9)), low Apgar score (adjusted OR 9.2 (CI 95% 1.9 to 45.2)), and multiple births (adjusted OR 7.1 (CI 95% 1.1 to 48.1)). Previous maternal thromboembolism and pregnancy-related disorders were not associated with the risk of thromboembolism in the children.</p></sec><sec><st>Conclusion</st><p>Several apparently independent infant, obstetrical and maternal characteristics were associated with thromboembolism in early life.</p></sec>]]></description>
<dc:creator><![CDATA[Tuckuviene, R., Christensen, A. L., Helgested, J., Hundborg, H. H., Kristensen, S. R., Johnsen, S. P.]]></dc:creator>
<dc:date>2012-03-13T02:01:38-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300665</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300665</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Stroke, Pregnancy, Child health]]></dc:subject>
<dc:title><![CDATA[Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study]]></dc:title>
<prism:publicationDate>2012-03-13</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301580v1?rss=1">
<title><![CDATA[Hepatocyte growth factor levels of cord blood in healthy term newborns]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301580v1?rss=1</link>
<description><![CDATA[<p>Hepatocyte growth factor (HGF) has been reported recently to be a prognostic factor of acute pulmonary disorders. Regarding the clinical relationships of HGF with neonates, Khan <I>et al</I> reported the cord blood serum HGF level in neonates in 1996.<cross-ref type="bib" refid="R1">1</cross-ref> Since the serum HGF level in normal neonates was 0.66 to 1.33 ng/dl, which was about three times higher than the adult reference value, and increased with the gestational age, they suggested that the cord blood serum HGF level reflects the state of fetal maturation. However, the expression of HGF is known to be induced by inflammatory cytokine,<cross-ref type="bib" refid="R2">2</cross-ref> and inflammatory cytokine levels increase in cord blood of neonates with fetal distress.<cross-ref type="bib" refid="R3">3</cross-ref> Therefore, the serum HGF level may rise in neonates distressed during delivery. In this study, we measured serum HGF in cord blood of term appropriate for date neonates born without reaching a non-reassuring fetal...]]></description>
<dc:creator><![CDATA[Hokuto, I., Matsuzaki, Y., Miwa, M., Arimitsu, T., Okishio, E., Ikeda, K.]]></dc:creator>
<dc:date>2012-02-28T02:03:49-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301580</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301580</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Hepatocyte growth factor levels of cord blood in healthy term newborns]]></dc:title>
<prism:publicationDate>2012-02-28</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301129v1?rss=1">
<title><![CDATA[Patent ductus arteriosus: time to grasp the nettle?]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301129v1?rss=1</link>
<description><![CDATA[<p>The management of patent ductus arteriosus is controversial, and there are diverse approaches to treatment, ranging from very conservative management through to early and aggressive securing of ductus closure, either pharmacologically or surgically. This lack of consensus on best management reflects a paucity of high quality randomised controlled trials, with many published studies focusing on establishing points of treatment, rather than looking for benefits of intervention over more conservative management. Despite this lack of good evidence views on ductus management can be entrenched, with accompanying loss of equipoise. This review looks at our current situation with regard to ductus arteriosus management and the need for good quality trials especially in the light of other published studies, concerning postnatal steroids, caffeine and oxygen which have demonstrated unexpected benefits &ndash; or sometimes unexpected harm &ndash; from long-familiar drugs.</p>]]></description>
<dc:creator><![CDATA[Smith, C. L., Kissack, C. M.]]></dc:creator>
<dc:date>2012-02-28T02:03:49-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301129</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301129</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Patent ductus arteriosus: time to grasp the nettle?]]></dc:title>
<prism:publicationDate>2012-02-28</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300766v1?rss=1">
<title><![CDATA[Superior vena cava flow and management of neonates with vein of Galen malformation]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300766v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>Vein of Galen malformation (VGAM) in neonates presents a complex management challenge. Measurement of superior vena cava (SVC) blood flow may provide insights into the haemodynamics of VGAM and the effects of therapeutic intervention.</p></sec><sec><st>Methods</st><p>SVC flow was assessed in 15 neonates with VGAM. SVC flow results, Bic&ecirc;tre scores (clinical assessment), echocardiographic assessment and clinical outcomes are presented.</p></sec><sec><st>Results</st><p>SVC flows (166&ndash;581 ml/kg/min) were significantly elevated at presentation (p&lt;0.001; normal range 55&ndash;111 ml/kg/min). Endovascular intervention was undertaken in 12 cases, with nine survivors. SVC flows decreased sequentially with each embolisation, with a median SVC flow at discharge of 124 ml/kg/min (IQR 79&ndash;155 ml/kg/min). All cases with SVC flow &gt;400 ml/kg/min (n=5) had an adverse outcome (death or profound neurological damage). Cases with SVC flow &lt;400 ml/kg (n=10) required embolisation before discharge at a median age of 6 days. There were no survivors with Bic&ecirc;tre scores &lt;8 (n=2) but the predictive value of early Bic&ecirc;tre score was poor.</p></sec><sec><st>Conclusions</st><p>SVC flow measurements provide insight into the haemodynamic challenges of VGAM and provide additional useful prognostic information.</p></sec>]]></description>
<dc:creator><![CDATA[Heuchan, A. M., Bhattacharyha, J.]]></dc:creator>
<dc:date>2012-02-28T02:03:49-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300766</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300766</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Echocardiography, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Superior vena cava flow and management of neonates with vein of Galen malformation]]></dc:title>
<prism:publicationDate>2012-02-28</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301482v1?rss=1">
<title><![CDATA[Being there: a qualitative interview study with fathers present during the resuscitation of their baby at delivery]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301482v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To explore fathers' experiences of the resuscitation of their baby at delivery.</p></sec><sec><st>Design</st><p>A descriptive, retrospective design using tape-recorded semistructured interviews with fathers present during the resuscitation of their baby at delivery. Fathers described what happened, their interactions with healthcare professionals, their feelings at the time and afterwards.</p></sec><sec><st>Setting</st><p>Participants were recruited from a large teaching hospital in the UK.</p></sec><sec><st>Participants</st><p>A purposive sample of 20 fathers whose baby required resuscitation at delivery.</p></sec><sec><st>Results</st><p>Participant responses were analysed using thematic analysis. Four broad themes were identified: &lsquo;preparation&rsquo;, &lsquo;knowing what happened&rsquo;, &lsquo;his response&rsquo; and &lsquo;impact on him&rsquo;. Fathers had no difficulty recalling their emotions during the resuscitation. These feelings remained vivid and were mostly negative. Most fathers wanted to go to their baby during the resuscitation but did not do so. They felt they should stay with their partner, did not want to impede the resuscitation or felt they were not &lsquo;allowed&rsquo; to go to their baby. The fathers' position in the room and the extent to which they were focusing on their partner had an impact on their recollection of what happened. Fathers had no opportunity to discuss the resuscitation with healthcare professionals afterwards. Several fathers felt they had not yet recovered from the experience and a few had symptoms synonymous with post-traumatic stress disorder.</p></sec><sec><st>Conclusion</st><p>This is the first study to specifically explore fathers' experiences of newborn resuscitation. The findings should inform healthcare education, policy development and the provision of support to fathers.</p></sec>]]></description>
<dc:creator><![CDATA[Harvey, M. E., Pattison, H. M.]]></dc:creator>
<dc:date>2012-02-28T02:03:49-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301482</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301482</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child and adolescent psychiatry (paedatrics), Child health, Infant health, Neonatal health, Anxiety disorders (including OCD and PTSD), Resuscitation]]></dc:subject>
<dc:title><![CDATA[Being there: a qualitative interview study with fathers present during the resuscitation of their baby at delivery]]></dc:title>
<prism:publicationDate>2012-02-28</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300820v1?rss=1">
<title><![CDATA[Demographics, clinical characteristics and outcomes of neonates diagnosed with fetomaternal haemorrhage]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300820v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To determine clinical characteristics, demographics and short-term outcomes of neonates diagnosed with fetomaternal haemorrhage (FMH).</p></sec><sec><st>Design</st><p>The authors analysed the Nationwide Inpatient Sample, 1993 to 2008. Singleton births diagnosed with FMH were identified by International Classification of Diseases (ICD-9) code 762.3. Descriptive, univariate and multivariable regression analyses were performed to determine the national annual incidence of FMH over time as well as demographics and clinical characteristics of neonates with FMH.</p></sec><sec><st>Results</st><p>FMH was identified in 12 116 singleton births. Newborns with FMH required high intensity of care: 26.3% received mechanical ventilation, 22.4% received blood product transfusion and 27.8% underwent central line placement. Preterm birth (OR 3.7), placental abruption (OR 9.8) and umbilical cord anomaly (OR 11.4) were risk factors for FMH. Higher patient income was associated with increased likelihood of FMH diagnosis (OR 1.2), and Whites were more likely to be diagnosed than ethnic minorities (OR 1.9). There was reduced frequency of diagnosis in the Southern USA (OR 0.8 vs the Northeastern USA).</p></sec><sec><st>Conclusions</st><p>Diagnosis of FMH is associated with significant morbidity as well as regional, socioeconomic and racial disparity. Further study is needed to distinguish between diagnostic coding bias and true epidemiology of the disease. This is the first report of socioeconomic and racial/ethnic disparities in FMH, which may represent disparities in detection that require national attention.</p></sec>]]></description>
<dc:creator><![CDATA[Stroustrup, A., Trasande, L.]]></dc:creator>
<dc:date>2012-02-28T02:03:48-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300820</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300820</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Pregnancy, Child health, Neonatal health, Mechanical ventilation]]></dc:subject>
<dc:title><![CDATA[Demographics, clinical characteristics and outcomes of neonates diagnosed with fetomaternal haemorrhage]]></dc:title>
<prism:publicationDate>2012-02-28</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301339v1?rss=1">
<title><![CDATA[Unique eyelid manifestations in type 1 pseudohypoaldosteronism]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301339v1?rss=1</link>
<description><![CDATA[<p>Familial pseudohypoaldosteronism type 1 (PHA1) occurs in two genetically and clinically distinguishable variants. Autosomal-recessive PHA1 that involves a genetic defect in the epithelial sodium channel that affects all aldosterone target organs including the kidney, colon and sweat glands.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref> Two published case reports describe Meibomian gland involvement.<cross-ref type="bib" refid="R3">3</cross-ref> <cross-ref type="bib" refid="R4">4</cross-ref></p><p>This image is of a female infant with PHA1 who displayed pathognomonic eyelid abnormality secondary to Meibomian gland dysfunction. The infant presented at the age of 6 days with lethargy and poor feeding. Laboratory findings revealed hyperkalaemia (potassium 10.2 mmol/l), hyponatraemia (sodium 129 mmol/l), bicarbonates measuring 21 mmol/l, anion gap of 13 meq/l and glucose at 4.9 mmol/l. Serum aldosterone level was 78.350 pmol/l (upper normal is 5500 pmol/l). Renin activity was also very high, &gt;116.73 &micro;g/l/h (normal maximum up to 5.7 &micro;g/l/h). The above values are diagnostic of PHA1. Meanwhile, serum cortisol, 17-hydroxyprogesterone levels,...]]></description>
<dc:creator><![CDATA[Nasir, A., Najab, I. A.]]></dc:creator>
<dc:date>2012-02-23T02:01:14-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301339</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301339</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Urology, Journalology, Ophthalmology, Renal medicine, Competing interests (ethics), Metabolic disorders]]></dc:subject>
<dc:title><![CDATA[Unique eyelid manifestations in type 1 pseudohypoaldosteronism]]></dc:title>
<prism:publicationDate>2012-02-23</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301479v1?rss=1">
<title><![CDATA[Early congenital syphilis in a premature newborn: typical cutaneous manifestations in atypical skin areas]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301479v1?rss=1</link>
<description><![CDATA[<p>The illustrated infant was birthed by an emergency caesarean section owing to placental abruption at 35 weeks of gestational age. The mother was serologically negative for relevant infections, except for a weakly-reactive Venereal Disease Research Laboratory (VDRL) test at the time of delivery.</p><p>Examination of the newborn revealed multiple widespread vesicular bullous eruption involving the back of hands and feet, some of which were already broken leaving a denuded and macerated area (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Also found were annular maculopapular lesions on the anterior surface of the thorax and abdomen, hepatosplenomegaly with elevated direct bilirubin, anaemia and leukaemoid blood picture.</p><p>Haematology revealed serum positive for enzyme immunoassay for treponemal immunoglobulin M, Treponema Pallidum Haemagglutination (1/5120) and VDRL (1/64). The cerebrospinal fluid VDRL test was negative.</p><p>A diagnosis of early congenital syphilis was made and was treated with parenteral penicillin G. The newborn showed improvement in the clinical conditions following treatment until discharge.</p><p>Manifestations...]]></description>
<dc:creator><![CDATA[Tana, M., Lio, A., Vento, G.]]></dc:creator>
<dc:date>2012-02-13T02:03:28-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301479</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301479</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Immunology (including allergy), Drugs: infectious diseases, Pregnancy, Sexual health, Dermatology, Competing interests (ethics), Research and publication ethics]]></dc:subject>
<dc:title><![CDATA[Early congenital syphilis in a premature newborn: typical cutaneous manifestations in atypical skin areas]]></dc:title>
<prism:publicationDate>2012-02-13</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300964v1?rss=1">
<title><![CDATA[Distribution and severity of hypoxic-ischaemic lesions on brain MRI following therapeutic cooling: selective head versus whole body cooling]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300964v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Whole body cooling (WBC) cools different parts of the brain uniformly, and selective head cooling (SHC) cools the superficial brain more than the deeper brain structures. In this study, the authors hypothesised that the hypoxic&ndash;ischaemic lesions on brain MRI following cooling would differ between modalities of cooling.</p></sec><sec><st>Aim</st><p>To compare the frequency, distribution and severity of hypoxic&ndash;ischaemic lesions on brain MRI between SHC or WBC.</p></sec><sec><st>Methods</st><p>In a single centre retrospective study, 83 infants consecutively cooled using either SHC (n=34) or WBC (n=49) underwent brain MRI. MRI images were evaluated by a neuroradiologist, who was masked to clinical parameters and outcomes, using a basal ganglia/watershed (BG/W) scoring system. Higher scores (on a scale of 0 to 4) were given for more extensive injury. The score has been reported to be predictive of neuromotor and cognitive outcome at 12 months.</p></sec><sec><st>Results</st><p>The two groups were similar for severity of depression as assessed by a history of an intrapartum sentinel event, Apgar scores, initial blood pH and base deficit and early neurological examination. However, abnormal MRI was more frequent in the SHC group (SHC 25 of 34, 74% vs WBC 22 of 49, 45%; p=0.0132, OR 3.4, 95% CI 1.3 to 8.8). Infants from the SHC group also had more severe hypoxic&ndash;ischaemic lesions (median BG/W score: SHC 2 vs WBC 0, p=0.0014).</p></sec><sec><st>Conclusions</st><p>Hypoxic&ndash;ischaemic lesions on brain MRI following therapeutic cooling were more frequent and more severe with SHC compared with WBC.</p></sec>]]></description>
<dc:creator><![CDATA[Sarkar, S., Donn, S. M., Bapuraj, J. R., Bhagat, I., Barks, J. D.]]></dc:creator>
<dc:date>2012-02-13T02:03:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300964</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300964</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Neuroimaging, Child and adolescent psychiatry (paedatrics), Child health]]></dc:subject>
<dc:title><![CDATA[Distribution and severity of hypoxic-ischaemic lesions on brain MRI following therapeutic cooling: selective head versus whole body cooling]]></dc:title>
<prism:publicationDate>2012-02-13</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301158v1?rss=1">
<title><![CDATA[Improved radiological assessment of neonatal feeding tubes]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301158v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>In about one-fifth of radiographs performed in neonates, no exact gastric feeding tube position can be defined.</p></sec><sec><st>Objectives</st><p>To determine whether injection of air via feeding tube before taking radiographs improves radiological assessment of its position.</p></sec><sec><st>Methods</st><p>In the study group (n=153), air was injected via gastric feeding tube before taking a radiograph. The tube position on radiographs was compared with a blinded control group (n=381) with no injection of air.</p></sec><sec><st>Results</st><p>The definition of exact gastric tube position was possible in 95% of the study group compared with 78% in the control group (p&lt;0.001).</p></sec><sec><st>Conclusion</st><p>Injection of air before taking a radiograph significantly improves the definition of exact gastric feeding tube position in neonates.</p></sec>]]></description>
<dc:creator><![CDATA[Quandt, D., Brons, E., Schiffer, P. M., Schraner, T., Bucher, H. U., Mieth, R. A.]]></dc:creator>
<dc:date>2012-02-06T22:24:07-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301158</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301158</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Improved radiological assessment of neonatal feeding tubes]]></dc:title>
<prism:publicationDate>2012-02-06</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301126v1?rss=1">
<title><![CDATA[Congenital dislocation of the knee]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301126v1?rss=1</link>
<description><![CDATA[<p>The neonatal senior house officer was called to attend a delivery of a term infant due to the presence of meconium-stained liquor. Antenatal scans had been normal, and the pregnancy was unremarkable. A baby girl was delivered by spontaneous vertex delivery in good condition. However, on initial assessment, it was noticed that her left leg was hyperextended to 120&deg; and the lower leg was facing outwards. The leg was moving actively and the knee could be passively flexed to 90&deg;. The knee was not tender or swollen. Further examination revealed a dislocatable left hip, but the rest of her systemic and musculoskeletal examinations were normal.</p><p>Congenital dislocation of the knee is a rare condition affecting 1 in 100 000 babies. It is more common in females and breech presentations. It can be associated with orthopaedic conditions including developmental dysplasia of the hip and talipes equinovarus. It can also be found with...]]></description>
<dc:creator><![CDATA[Mottershead, N. J., Patel, U. D., Reynolds, P.]]></dc:creator>
<dc:date>2012-02-03T01:23:58-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301126</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301126</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Pregnancy, Reproductive medicine, Rheumatology, Sexual health, Dermatology, Competing interests (ethics), Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Congenital dislocation of the knee]]></dc:title>
<prism:publicationDate>2012-02-03</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300631v2?rss=1">
<title><![CDATA[Epidemiology of small intestinal atresia in Europe: a register-based study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300631v2?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>The epidemiology of congenital small intestinal atresia (SIA) has not been well studied. This study describes the presence of additional anomalies, pregnancy outcomes, total prevalence and association with maternal age in SIA cases in Europe.</p></sec><sec><st>Methods</st><p>Cases of SIA delivered during January 1990 to December 2006 notified to 20 EUROCAT registers formed the population-based case series. Prevalence over time was estimated using multilevel Poisson regression, and heterogeneity between registers was evaluated from the random component of the intercept.</p></sec><sec><st>Results</st><p>In total 1133 SIA cases were reported among 5126, 164 registered births. Of 1044 singleton cases, 215 (20.6%) cases were associated with a chromosomal anomaly. Of 829 singleton SIA cases with normal karyotype, 221 (26.7%) were associated with other structural anomalies. Considering cases with normal karyotype, the total prevalence per 10 000 births was 1.6 (95% CI 1.5 to 1.7) for SIA, 0.9 (95% CI 0.8 to 1.0) for duodenal atresia and 0.7 (95% CI 0.7 to 0.8) for jejunoileal atresia (JIA). There was no significant trend in SIA, duodenal atresia or JIA prevalence over time (RR=1.0, 95% credible interval (CrI): 1.0 to 1.0 for each), but SIA and duodenal atresia prevalence varied by geographical location (p=0.03 and p=0.04, respectively). There was weak evidence of an increased risk of SIA in mothers aged less than 20 years compared with mothers aged 20 to 29 years (RR=1.3, 95% CrI: 1.0 to 1.8).</p></sec><sec><st>Conclusion</st><p>This study found no evidence of a temporal trend in the prevalence of SIA, duodenal atresia or JIA, although SIA and duodenal atresia prevalence varied significantly between registers.</p></sec>]]></description>
<dc:creator><![CDATA[Best, K. E., Tennant, P. W. G., Addor, M.-C., Bianchi, F., Boyd, P., Calzolari, E., Dias, C. M., Doray, B., Draper, E., Garne, E., Gatt, M., Greenlees, R., Haeusler, M., Khoshnood, B., McDonnell, B., Mullaney, C., Nelen, V., Randrianaivo, H., Rissmann, A., Salvador, J., Tucker, D., Wellesly, D., Rankin, J.]]></dc:creator>
<dc:date>2012-02-01T03:24:32-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300631</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300631</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Small intestine, Stomach and duodenum, Pregnancy, Reproductive medicine]]></dc:subject>
<dc:title><![CDATA[Epidemiology of small intestinal atresia in Europe: a register-based study]]></dc:title>
<prism:publicationDate>2012-02-01</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300752v1?rss=1">
<title><![CDATA[Risk factors for early sudden deaths and severe apparent life-threatening events]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300752v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To identify potential risk factors for unexpected sudden infant deaths (SID) and severe apparent life-threatening events (S-ALTE) within 24 h of birth.</p></sec><sec><st>Design</st><p>Case-control study embedded in an epidemiological survey over a 2-year period.</p></sec><sec><st>Patients and methods</st><p>Throughout 2009, every paediatric department in Germany was asked to report cases of unexplained SID or S-ALTE in term infants with a 10-min Apgar score &ge;8 to the Surveillance Unit for Rare Pediatric Conditions. Throughout 2010, the inclusion criteria were extended to infants &ge;35 week gestational age and those where an explanation for the deterioration had been found. For each unexplained case, hospitals were asked to fill in a questionnaire for 3 (near-)term controls with good postnatal adaptation at the age (in minutes) when the event had occurred in the case under study.</p></sec><sec><st>Results</st><p>Of the 85 cases reported, 34 fulfilled the entry criteria; of these, two were near-term newborns and, in three cases, a cause had been identified for the event. For the 31 cases with unknown cause for the event (13 males; mean (SD) gestational age 38.9 (1.7) week), the authors gathered 93 controls (51 male infants; 38.9 (1.4) week). As significant risk factors for S-ALTE and SID, the authors could identify primipara (OR 6.22; 95% CI 2.11 to 18.32) and potentially asphyxiating position (OR 6.45; 95% CI 1.22 to 34.10).</p></sec><sec><st>Conclusions</st><p>Close observation of newborns seems necessary, particularly in primipara; a potentially asphyxiating position should be avoided.</p></sec>]]></description>
<dc:creator><![CDATA[Poets, A., Urschitz, M. S., Steinfeldt, R., Poets, C. F.]]></dc:creator>
<dc:date>2012-01-31T04:30:20-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300752</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300752</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Child health, Infant health, SIDS]]></dc:subject>
<dc:title><![CDATA[Risk factors for early sudden deaths and severe apparent life-threatening events]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300763v1?rss=1">
<title><![CDATA[Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300763v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study whether the incidence of intraventricular haemorrhage (IVH) in very premature infants (&lt;32 weeks gestation) with thrombocytopaenia is lower when using a liberal platelet-transfusion guideline compared with a restrictive guideline.</p></sec><sec><st>Study design</st><p>A retrospective cohort study comparing the incidence of IVH in very premature infants with thrombocytopaenia (platelet count &lt;150<FONT FACE="arial,helvetica">x</FONT>10<sup>9</sup>/l) admitted between 2007 and 2008 to two neonatal intensive care unit in The Netherlands. The restrictive platelet-transfusion unit (N=353 infants &lt;32 weeks gestation) transfused only in case of active haemorrhage and a platelet count &lt;50<FONT FACE="arial,helvetica">x</FONT>10<sup>9</sup>/l. The liberal-transfusion unit (N=326 infants &lt;32 weeks gestation) transfused according to predefined platelet count thresholds. Primary outcome was the incidence and severity of IVH in infants with thrombocytopaenia in both units.</p></sec><sec><st>Results</st><p>The number of infants with thrombocytopaenia that received a platelet transfusion was significantly lower in the restrictive-transfusion unit compared with the liberal-transfusion unit, 15% (21/145) versus 31% (41/141), (p&lt;0.001). The incidence of IVH in infants with thrombocytopaenia in the restrictive-transfusion and liberal-transfusion units was 30% (44/145) and 29% (41/141), respectively (p=0.81). The incidence of severe IVH (grade 3 or 4) in the restrictive-transfusion and liberal-transfusion units was 8% (12/145) and 11% (16/141), respectively (p=0.38).</p></sec><sec><st>Conclusion</st><p>In the restrictive-transfusion unit, the rate of platelet transfusions was significantly lower, but the incidence and severity of IVH was similar to the liberal-transfusion unit.</p></sec>]]></description>
<dc:creator><![CDATA[von Lindern, J. S., Hulzebos, C. V., Bos, A. F., Brand, A., Walther, F. J., Lopriore, E.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300763</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300763</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Thrombocytopaenia and intraventricular haemorrhage in very premature infants: a tale of two cities]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300578v1?rss=1">
<title><![CDATA[C reactive protein: impact on peripheral tissue oxygenation and perfusion in neonates]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300578v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>C reactive protein (CRP) is a sensitive marker of acute inflammation of infectious and non-infectious origin. Aim was to use near-infrared spectroscopy (NIRS) to analyse peripheral oxygenation and perfusion in term and preterm neonates with elevated CRP levels, at a time when routine haemodynamic variables are still normal.</p></sec><sec><st>Design</st><p>Prospective observational study.</p></sec><sec><st>Settings</st><p>Peripheral-muscle NIRS was performed in the first week of life. Tissue-oxygenation index (TOI), mixed venous oxygenation (SvO<SUB>2</SUB>), fractional oxygen extraction (FOE), haemoglobin flow (Hbflow), oxygen delivery (DO<SUB>2</SUB>) and oxygen consumption (VO<SUB>2</SUB>) were assessed. Blood samples were taken within 3 h of the NIRS measurements.</p></sec><sec><st>Patients</st><p>Cardiocirculatory stable term and preterm neonates with infection-related and infection-unrelated CRP elevations &gt;10 mg/l were compared with neonates without CRP elevation. The two groups were matched for gestational and postnatal age.</p></sec><sec><st>Results</st><p>33 neonates with CRP elevation (gestational age 37.7&plusmn;2.9 weeks) were compared with 33 controls (gestational age 37.3&plusmn;2.9 weeks). In neonates with CRP elevation, TOI (68.9&plusmn;6.6%), SvO<SUB>2</SUB> (66.9&plusmn;7.3%) DO<SUB>2</SUB> (39.2&plusmn;16.1 &micro;mol/100ml/min) and VO<SUB>2</SUB> (10.9&plusmn;3.4 &micro;mol/100ml/min) were significantly lower compared with controls (TOI 72.9&plusmn;3.8%, SvO<SUB>2</SUB> 70.2&plusmn;4.7%, DO<SUB>2</SUB> 48.8&plusmn;18.4 &micro;mol/100ml/min, VO<SUB>2</SUB> 12.3&plusmn;3.8 &micro;mol/100ml/min). There was no significant difference in any other NIRS or routine haemodynamic parameter between the two groups.</p></sec><sec><st>Conclusion</st><p>Inflammatory processes with CRP elevation cause impaired peripheral oxygenation and perfusion in neonates even when routine haemodynamic variables are still normal. NIRS might offer a new non-invasive tool for the early recognition and diagnosis of infectious and non-infectious inflammatory processes.</p></sec>]]></description>
<dc:creator><![CDATA[Pichler, G., Pocivalnik, M., Riedl, R., Pichler-Stachl, E., Zotter, H., Muller, W., Urlesberger, B.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300578</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300578</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Immunology (including allergy), Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[C reactive protein: impact on peripheral tissue oxygenation and perfusion in neonates]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300969v1?rss=1">
<title><![CDATA[Study of the costs and morbidities of late-preterm birth]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300969v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare late-preterm infants (33&ndash;36 weeks) with term infants (&ge;37 weeks) on incidence of morbidities in the first 3 years of life and healthcare costs during the first 2 years of life and third year of life.</p></sec><sec><st>Methods</st><p>Administrative health records of live infants born between January 1, 1997, and December 31, 2000 with 3 years follow-up data (N=35733) were linked. First, diagnoses of morbidities were compared between late-preterm and term infants using Cox's proportional hazards models. Healthcare costs expressed as mean total costs and cost ratios, accrued following initial hospital discharge after birth, were also examined.</p></sec><sec><st>Results</st><p>The three most common reasons for hospitalisation in late-preterm and term infants were acute bronchitis, otitis media and pneumonia. The most frequent reasons for physician visits included acute upper respiratory infections, otitis media and bronchiolitis. The highest HR were detected for chronic bronchitis 1.64 (1.13&ndash;2.39), hearing loss 1.56 (1.14&ndash;2.15) and bacterial diseases 1.28 (1.09&ndash;1.49). The mean total cost for late-preterm infants during the first 2 years of life was $2568 CAD compared with $1285 CAD for term infants, cost ratio =1.99 (95% CI 1.90 to 2.09). In the third year of life, the cost ratio reduced to 1.46 (95% CI 1.39 to 1.54).</p></sec><sec><st>Conclusions</st><p>Late-preterm infants are at higher risk of specific morbidities compared with term infants. Their mean total costs fall from almost double that of term infants during the first 2 years of life, to just 46% greater in the third year of life.</p></sec>]]></description>
<dc:creator><![CDATA[Berard, A., Le Tiec, M., De Vera, M. A.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300969</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300969</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Health policy, Epidemiologic studies, Bronchiolitis, Otitis, Pneumonia (infectious disease), TB and other respiratory infections, Child health, Infant health, Bronchitis, Pneumonia (respiratory medicine), Ear, nose and throat/otolaryngology, Health economics, Health service research]]></dc:subject>
<dc:title><![CDATA[Study of the costs and morbidities of late-preterm birth]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301090v1?rss=1">
<title><![CDATA[Continuous non-invasive cardiac output measurements in the neonate by electrical velocimetry: a comparison with echocardiography]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301090v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>Electrical velocimetry (EV) is a non-invasive method of continuous left cardiac output monitoring based on measurement of thoracic electrical bioimpedance. The objective was to validate EV by investigating the agreement in cardiac output measurements performed by EV and echocardiography.</p></sec><sec><st>Design</st><p>In this prospective observational study, left ventricular output (LVO) was simultaneously measured by EV (LVO<SUB>ev</SUB>) using Aesculon and by echocardiography (LVO<SUB>echo</SUB>) in healthy term neonates during the first 2 postnatal days. To determine the agreement between the two methods, we calculated the bias (mean difference) and precision (1.96<FONT FACE="arial,helvetica">x</FONT>SD of the difference). As LVO<SUB>echo</SUB> has its own limitations, the authors also calculated the &lsquo;true precision&rsquo; of EV adjusted for echocardiography as the reference method.</p></sec><sec><st>Results</st><p>The authors performed 115 paired measurements in 20 neonates. LVO<SUB>ev</SUB> and LVO<SUB>echo</SUB> were similar (534&plusmn;105 vs 538&plusmn;105 ml/min, p=0.7). The bias and precision of EV were &ndash;4 and 234 ml/min, respectively. The authors found the true precision of EV to be similar to the precision of echocardiography (31.6% vs 30%, respectively). There was no difference in bias and precision between the measurements obtained in patients with or without a haemodynamically significant patent ductus arteriosus.</p></sec><sec><st>Conclusions</st><p>EV is as accurate in measuring LVO as echocardiography and the variation in the agreement between EV and echocardiography among the individual subjects reflects the limitations of both techniques.</p></sec>]]></description>
<dc:creator><![CDATA[Noori, S., Drabu, B., Soleymani, S., Seri, I.]]></dc:creator>
<dc:date>2012-01-31T03:43:05-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301090</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301090</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Congenital heart disease, Echocardiography, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Continuous non-invasive cardiac output measurements in the neonate by electrical velocimetry: a comparison with echocardiography]]></dc:title>
<prism:publicationDate>2012-01-31</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300716v2?rss=1">
<title><![CDATA[Cooling and seizure burden in term neonates: an observational study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300716v2?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To investigate any possible effect of cooling on seizure burden, the authors quantified the recorded electrographic seizure burden based on multichannel video-EEG recordings in term neonates with hypoxic-ischaemic encephalopathy (HIE) who received cooling and in those who did not.</p></sec><sec><st>Study design</st><p>Retrospective observational study.</p></sec><sec><st>Patients</st><p>Neonates &gt;37 weeks gestation born between 2003 and 2010 in two hospitals.</p></sec><sec><st>Methods</st><p>Off-line analysis of prolonged continuous multichannel video-EEG recordings was performed independently by two experienced encephalographers. Comparison between the recorded electrographic seizure burden in non-cooled and cooled neonates was assessed. Data were treated as non-parametric and expressed as medians with interquartile ranges (IQR).</p></sec><sec><st>Results</st><p>One hundred and seven neonates with HIE underwent prolonged continuous multichannel EEG monitoring. Thirty-seven neonates had electrographic seizures, of whom 31 had EEG recordings that were suitable for the analysis (16 non-cooled and 15 cooled). Compared with non-cooled neonates, multichannel EEG monitoring commenced at an earlier postnatal age in cooled neonates (6 (3&ndash;9) vs 15 (5&ndash;20) h)and continued for longer (88 (75&ndash;101) vs 55 (41&ndash;60) h). Despite this increased opportunity to capture seizures in cooled neonates, the recorded electrographic seizure burden in the cooled group was significantly lower than in the non-cooled group (60 (39&ndash;224) vs 203 (141&ndash;406) min). Further exploratory analysis showed that the recorded electrographic seizure burden was only significantly reduced in cooled neonates with moderate HIE (49 (26&ndash;89) vs 162 (97&ndash;262) min).</p></sec><sec><st>Conclusions</st><p>A decreased seizure burden was seen in neonates with moderate HIE who received cooling. This finding may explain some of the therapeutic benefits of cooling seen in term neonates with moderate HIE.</p></sec>]]></description>
<dc:creator><![CDATA[Low, E., Boylan, G. B., Mathieson, S. R., Murray, D. M., Korotchikova, I., Stevenson, N. J., Livingstone, V., Rennie, J. M.]]></dc:creator>
<dc:date>2012-01-23T01:07:31-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300716</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300716</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epilepsy and seizures, Child health]]></dc:subject>
<dc:title><![CDATA[Cooling and seizure burden in term neonates: an observational study]]></dc:title>
<prism:publicationDate>2012-01-23</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300244v1?rss=1">
<title><![CDATA[Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300244v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Within the ORACLE Children Study Cohort, the authors have evaluated long-term consequences of the diagnosis of confirmed or suspected neonatal necrotising enterocolitis (NEC) at age of 7 years.</p></sec><sec><st>Methods</st><p>Outcomes were assessed using a parental questionnaire, including the Health Utilities Index (HUI-3) to assess functional impairment, and specific medical and behavioural outcomes. Educational outcomes for children in England were explored using national standardised tests. Multiple logistic regression was used to explore independent associates of NEC within the cohort.</p></sec><sec><st>Results</st><p>The authors obtained data for 119 (77%) of 157 children following proven or suspected NEC and compared their outcomes with those of the remaining 6496 children. NEC was associated with an increase in risk of neonatal death (OR 14.6 (95% CI 10.4 to 20.6)).</p><p>At 7 years, NEC conferred an increased risk of all grades of impairment. Adjusting for confounders, risks persisted for any HUI-3 defined functional impairment (adjusted OR 1.55 (1.05, 2.29)), particularly mild impairment (adjusted OR 1.61 (1.03, 2.53)) both in all NEC children and in those with proven NEC, which appeared to be independent. No behavioural or educational associations were confirmed. Following NEC, children were more likely to suffer bowel problems than non-NEC children (adjusted OR 3.96 (2.06, 7.61)).</p></sec><sec><st>Conclusions</st><p>The ORACLE Children Study provided opportunity for the largest evaluation of school age outcome following neonatal NEC and demonstrates significant long-term consequences of both gut function (presence of stoma, admission for bowel problems and continuing medical care for gut-related problems) and motor, sensory and cognitive outcomes as measured using HUI-3.</p></sec>]]></description>
<dc:creator><![CDATA[Pike, K., Brocklehurst, P., Jones, D., Kenyon, S., Salt, A., Taylor, D., Marlow, N.]]></dc:creator>
<dc:date>2012-01-20T23:39:10-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300244</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300244</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study]]></dc:title>
<prism:publicationDate>2012-01-20</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301388v1?rss=1">
<title><![CDATA[The stoma that appeared from nowhere]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301388v1?rss=1</link>
<description><![CDATA[<p>A term baby with normal antenatal scans was postnatally diagnosed as having oesophageal atresia (OA) with tracheoesophageal fistula and an imperforate anus. The child had an umbilical venous catheter inserted, which was removed prior to surgery on day 2 of life. The OA was repaired and a divided colostomy was created. On day 8 postop, the nurse caring for the child enquired &lsquo;How do we look after the third stoma?&rsquo; (The nurse noted a third stoma at the umbilicus.) On examination, there was a protrusion from the umbilicus that resembled a perfectly formed stoma. No discharge was noted. A 6 Fr feeding tube inserted into this stoma revealed intestinal contents demonstrating that this was a patent vitello-intestinal duct. This stoma is currently under observation and it will be excised at the time of future laparotomy.</p><p>During the development of the midgut, a primary intestinal loop is formed as a result of...]]></description>
<dc:creator><![CDATA[Kuti, K., Paul, A., Desai, A.]]></dc:creator>
<dc:date>2012-01-20T23:39:10-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301388</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301388</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Oesophagus, Reproductive medicine, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[The stoma that appeared from nowhere]]></dc:title>
<prism:publicationDate>2012-01-20</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300907v1?rss=1">
<title><![CDATA[Purpura fulminans in an acute preterm neonate]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300907v1?rss=1</link>
<description><![CDATA[<p>A baby was delivered by ventouse assistance at 35+6 weeks gestation following prolonged rupture of membranes and fetal distress in the second stage of labour. He was started on intravenous cefotaxime but at 13 h of age deteriorated with signs of septic shock and respiratory distress. He was admitted to the neonatal intensive care unit for resuscitation and ventilation. Blood cultures taken at 3 h of age confirmed a gram-negative septicaemia (fully sensitive <I>Escherichia coli</I>). Examination of the skin on day 2 revealed patchy purpura (initially on the neck, lip, sacrum and scrotum) and a right parietal cephalohaematoma. Cutaneous necrosis ensued in a number of these lesions, most marked on the posterior occiput (<cross-ref type="fig" refid="F1">figure 1</cross-ref>).</p><p>All skin lesions were managed conservatively with daily dressing changes, gel cushioning and 4 hourly position changes to relieve pressure. Gentle debridement was carried out at intervals under analgesia and with burns specialist nurse...]]></description>
<dc:creator><![CDATA[Church, J., Haram, N. H., Jones, I., Hartnoll, G.]]></dc:creator>
<dc:date>2012-01-20T00:12:49-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300907</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300907</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Immunology (including allergy), Drugs: infectious diseases, Pain (neurology), Hypertension, Pregnancy, Pain (palliative care), Competing interests (ethics), Resuscitation, Trauma]]></dc:subject>
<dc:title><![CDATA[Purpura fulminans in an acute preterm neonate]]></dc:title>
<prism:publicationDate>2012-01-20</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301200v1?rss=1">
<title><![CDATA[Term neonates receiving intensive care at high risk of brainstem auditory impairment]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301200v1?rss=1</link>
<description><![CDATA[<p>Functional integrity of the auditory brainstem was examined using maximum length sequence brainstem auditory evoked response in 72 term neonates who were receiving intensive care. Compared with normal term controls, the neonates receiving intensive care showed an increase in wave V latency and I to V and III to V interpeak intervals of the response. Wave V latency was significantly increased at very high click rates 455 and 910/s. I to V and III to V intervals were significantly increased at all 91 to 910/s, particularly 455 and 910/s, while I to III intervals were slightly increased. III to V/I to III interval ratios were increased at 455 and 910/s clicks. The slopes of wave V latency-rate, I to V interval-rate, III to V interval-rate and III to V/I to III-interval-ratio-rate functions were significantly steeper than in normal controls. These abnormalities suggest that neonates receiving intensive care are at high risk of brainstem, mainly more central regions, auditory impairment. The MLS BAER abnormalities and brainstem auditory impairment might be the result of collective adverse effects, produced by more than one perinatal risk factor.</p>]]></description>
<dc:creator><![CDATA[Jiang, Z., Brosi, D., Yin, R., Wilkinsin, A. R.]]></dc:creator>
<dc:date>2012-01-19T00:40:00-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301200</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301200</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Neonatal and paediatric intensive care, Neonatal health, Disability]]></dc:subject>
<dc:title><![CDATA[Term neonates receiving intensive care at high risk of brainstem auditory impairment]]></dc:title>
<prism:publicationDate>2012-01-19</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301235v1?rss=1">
<title><![CDATA[Congenital right-sided para-umbilical abdominal wall hernia]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301235v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Case report</st><p>A 34-week gestation baby was born to a 45-year-old opiate dependent mother with limited prenatal care. Examination demonstrated a large skin-covered, right-sided para-umbilical mass, measuring 12<FONT FACE="arial,helvetica">x</FONT>14 cm, increasing in size with cry (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Umbilical ring was well formed and present around left base of the defect. On palpation, margins of the defect were smooth and intestines were reducible.</p><p>Abdominal film and upper gastrointestinal series showed a right-sided abdominal mass filled with loops of bowel. Sonographic evaluation revealed lack of abdominal wall muscles overlying the defect, whereas the peritoneal sac, other intra-abdominal organs, heart and intracranial structures were normal.</p><p>Surgical exploration revealed a hernial sac measuring 4<FONT FACE="arial,helvetica">x</FONT>4 cm with a substantial rim of surrounding fascia. There was no evidence of liver herniation or abnormality in its attachment. Bowel malrotation was evident and Ladd's procedure was performed. Fascial defect was approximated without any tension and was closed primarily in...]]></description>
<dc:creator><![CDATA[Ku, L., Kalra, V. K., Salinas, S., Chouthai, N., Pappas, A., Langenburg, S. E.]]></dc:creator>
<dc:date>2012-01-17T04:10:23-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301235</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301235</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Reproductive medicine, Neonatal and paediatric intensive care, Neonatal intensive care, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Congenital right-sided para-umbilical abdominal wall hernia]]></dc:title>
<prism:publicationDate>2012-01-17</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301464v1?rss=1">
<title><![CDATA[Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009]]></title>
<link>http://fn.bmj.com/cgi/content/short/fetalneonatal-2011-301464v1?rss=1</link>
<description><![CDATA[<p>Retinopathy of prematurity (ROP) is a disorder of retinal vascular development in premature infants and is a major cause of childhood blindness worldwide. Dhaliwal <I>et al</I> conducted a prospective, population-based study looking at the incidence of ROP in the Lothian region of south-east Scotland from 1990 to 2004 and found the following<cross-ref type="bib" refid="R1">1</cross-ref>:<l type="tab"><li><p>(1) Significant increase in survival of infants with birth weight &lt;1500 g and/or gestational age &lt;32 weeks</p></li><li><p>(2) Significant reduction in the number of infants treated for ROP</p></li><li><p>(3) Reduction in the incidence of any degree of ROP and severe (stage 3 or greater) ROP although both did not reach statistical significance.</p></li></l></p><p>Treatment criteria for ROP have changed in Lothian since the publication of the Early Treatment for Retinopathy of Prematurity (ETROP) study.<cross-ref type="bib" refid="R2">2</cross-ref> Before January 2005, infants with &lsquo;threshold&rsquo; or &lsquo;plus&rsquo; disease were treated. After January 2005, &lsquo;type 1&rsquo; ROP as defined by ETROP, stage 2 or...]]></description>
<dc:creator><![CDATA[Tan, S. Z., Dhaliwal, C., Becher, J.-C., Fleck, B.]]></dc:creator>
<dc:date>2012-01-12T20:21:47-08:00</dc:date>
<dc:identifier>info:doi/10.1136/fetalneonatal-2011-301464</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;fetalneonatal-2011-301464</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Trends in the incidence of retinopathy of prematurity in Lothian, south-east Scotland, from 1990 to 2009]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>PostScript</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301209v1?rss=1">
<title><![CDATA[Fetiform sacrococcygeal teratoma]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301209v1?rss=1</link>
<description><![CDATA[<p>Sacrococcygeal tumours (SCT's) are the common tumours of the neonatal age group; occasionally the appearance may mimic a sacral parasitic conjoined twin (SPCT). It is important to differentiate between the two as the former carries malignant potential and needs rigorous follow-up. This report highlights the differentiating features between the two entities.</p><p>A neonate was presented to us with a sacral mass of fetiform appearance (<cross-ref type="fig" refid="F1">figure 1A</cross-ref>). The radiological (<cross-ref type="fig" refid="F1">figure 1B</cross-ref>) and biochemical tests were unable to differentiate between SCT and SPCT. The mass was excised completely; histopathological examination confirmed the diagnosis of mature SCT. The differential diagnosis in our case was a SPCT. This is a rare anomaly with an incomplete twin (parasite) attached to the sacrococcygeal region of the co-twin (autosite). The differentiation between these two is important as SCT's carry malignant potential.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref></p><p>A parasitic twin can have recognisable body parts such...]]></description>
<dc:creator><![CDATA[Kattepura, S., Sahadev, R., Munianjanappa, N., Shankar, G., Santhanakrishnan, R.]]></dc:creator>
<dc:date>2012-01-12T23:53:28-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301209</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301209</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Journalology, Reproductive medicine, Competing interests (ethics)]]></dc:subject>
<dc:title><![CDATA[Fetiform sacrococcygeal teratoma]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300412v1?rss=1">
<title><![CDATA[Geographical disparities of infant mortality in rural China]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300412v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>The purpose of the study was to investigate the trends and causes of regional disparities of infant mortality rate (IMR) in rural China from 1996 to 2008.</p></sec><sec><st>Design</st><p>A population-based, longitudinal study.</p></sec><sec><st>Setting</st><p>The national child mortality surveillance network.</p></sec><sec><st>Population</st><p>Population of the 79 surveillance counties.</p></sec><sec><st>Main outcome measure</st><p>IMR, leading causes of infant death and the RR of IMR.</p></sec><sec><st>Results</st><p>The IMR in coastal, inland and remote regions declined by 72.4%, 62.9% and 58.2%, respectively, from 1996 to 2008. Compared with the coastal region, the RR of IMR were 1.7 (95% CI 1.6 to 1.9), 1.9 (95% CI 1.7 to 2.0) and 1.8 (95% CI 1.6 to 2.0) for inland region and 2.6 (95% CI 2.4 to 2.7), 3.2 (95% CI 3.0 to 3.5) and 3.1 (95% CI 2.7 to 3.4) for the remote region during 1996&ndash;2000, 2001&ndash;2005 and 2006&ndash;2008, respectively. The regional disparities existed for both male and female IMRs. The postneonatal mortality showed the highest regional disparities. Pneumonia, birth asphyxia, prematurity/low birth weight, injuries and diarrhoea were the main contributors to the regional disparities. There were significantly more infants who did not seek healthcare services before death in the remote region relative to the inland and coastal regions.</p></sec><sec><st>Conclusion</st><p>The results indicated persistent existence of regional disparities in IMR in rural China. It is worth noting that regional disparities in IMR increased in the remote and coastal regions during 2001&ndash;2005 in rural China. These disparities remained unchanged during 2006&ndash;2008. The results indicate that strategies to reduce mortality caused by pneumonia, birth asphyxia and diarrhoea are keys to reducing IMR.</p></sec>]]></description>
<dc:creator><![CDATA[Wang, Y., Zhu, J., He, C., Li, X., Miao, L., Liang, J.]]></dc:creator>
<dc:date>2012-01-12T23:53:28-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300412</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300412</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Diarrhoea, Epidemiologic studies, Unlocked, Pneumonia (infectious disease), TB and other respiratory infections, Child health, Pneumonia (respiratory medicine), Trauma, Injury]]></dc:subject>
<dc:title><![CDATA[Geographical disparities of infant mortality in rural China]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300405v1?rss=1">
<title><![CDATA[Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300405v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study risk factors and cranial ultrasound (cUS) findings in a large cohort of preterm infants, admitted to a neonatal intensive care unit and diagnosed with postnatally acquired cytomegalovirus (CMV) infection.</p></sec><sec><st>Study design</st><p>This prospective, observational study was performed from April 2007 until June 2009 among 315 infants born &lt;32 weeks of gestation. Postnatal CMV infection was diagnosed by CMV PCR on urine collected at term-equivalent age. In CMV-positive infants, congenital infection was excluded. The authors compared the clinical and demographic data, feeding pattern and cUS results of infected and non-infected patients. Logistic regression analysis was performed.</p></sec><sec><st>Results</st><p>In 39 of 315 infants, the diagnosis of postnatal CMV infection has been made. The majority of CMV-infected infants (33/39.85%) did not develop any symptoms of CMV infection. The most important, independent risk factors of postnatal CMV infection were non-native Dutch maternal origin (OR 9.6 (95% CI 4.3 to 21.5)) and breast milk (OR 13.2 (95% CI 1.7 to 104.5)). The risk of infection significantly increased in infants with lower gestational age (GA) (OR 0.7 (95% CI 0.5 to 0.9)). Lenticulostriate vasculopathy (LSV) was significantly more often present in infants with CMV infection (OR 4.1 (95% CI 1.9 to 8.8)).</p></sec><sec><st>Conclusions</st><p>Postnatal CMV infection is an asymptomatic infection among preterm infants. Infants with lower GA are at greatest risk of postnatal CMV infection, especially when fed with fresh breast milk from their non-native Dutch mother. LSV not present at birth but confirmed at term-equivalent age can suggest a postnatal CMV infection.</p></sec>]]></description>
<dc:creator><![CDATA[Nijman, J., de Vries, L. S., Koopman-Esseboom, C., Uiterwaal, C. S. P. M., van Loon, A. M., Verboon-Maciolek, M. A.]]></dc:creator>
<dc:date>2012-01-12T23:53:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300405</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300405</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Childhood nutrition, Reproductive medicine, Child health, Infant health, Infant nutrition (including breastfeeding), Neonatal health, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301008v1?rss=1">
<title><![CDATA[Trends and centre-to-centre variability in survival rates of very preterm infants (<32 weeks) over a 10-year-period in Switzerland]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301008v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>The publication of Swiss guidelines for the care of infants at the limit of viability (22&ndash;25 completed weeks) was followed by increased survival rates in the more mature infants (25 completed weeks). At the same time, considerable centre-to-centre (CTC) differences were noted.</p></sec><sec><st>Objectives</st><p>To examine the trend of survival rates of borderline viable infants over a 10-year-period and to further explore CTC differences.</p></sec><sec><st>Design</st><p>Population-based, retrospective cohort study.</p></sec><sec><st>Setting</st><p>All nine level III neonatal intensive care units (NICUs) and affiliated paediatric hospitals in Switzerland.</p></sec><sec><st>Patients</st><p>6532 preterm infants with a gestational age (GA) &lt;32 weeks born alive between 1 January 2000 and 31 December 2009.</p></sec><sec><st>Main outcome measures</st><p>Trends of GA-specific delivery room and NICU mortality rates and survival rates to hospital discharge were assessed. For CTC comparisons, centre-specific risk-adjusted ORs for survival were calculated in three GA groups: A: 23 0/7 to 25 6/7 weeks (n=976), B: 26 0/7 to 28 6/7 weeks (n=1943) and C: 29 0/7 to 31 6/7 weeks (n=3399).</p></sec><sec><st>Results</st><p>Survival rates of infants with a GA of 25 completed weeks which had improved from 42% in 2000/2001 to 60% in 2003/2004 remained unchanged at 63% over the next 5 years (2005&ndash;2009). Statistically significant CTC differences have persisted and are not restricted to borderline viable infants.</p></sec><sec><st>Conclusions</st><p>In Switzerland, survival rates of infants born at the limit of viability have remained unchanged over the second half of the current decade. Risk-adjusted CTC outcome variability cannot be explained by differences in baseline demographics or centre case loads.</p></sec>]]></description>
<dc:creator><![CDATA[Berger, T. M., Steurer, M. A., Woerner, A., Meyer-Schiffer, P., Adams, M., for the Swiss Neonatal Network]]></dc:creator>
<dc:date>2012-01-12T23:53:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301008</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301008</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Epidemiologic studies, Unlocked, Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Trends and centre-to-centre variability in survival rates of very preterm infants (<32 weeks) over a 10-year-period in Switzerland]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300773v1?rss=1">
<title><![CDATA[Visible thyroid ectopia]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300773v1?rss=1</link>
<description><![CDATA[<p>A 29-day-old infant was referred by the newborn screening laboratory with mild but persistent capillary thyroid stimulating hormone (TSH) elevation: 11 mU/l on day 5 of life and 19.5 mU/l on day 23. He was born in the 39th week by planned caesarean section weighing 3814 g and was discharged home on day 3 without any health concerns. However, his mother had noticed a small lump on his neck which she took to be the baby's &lsquo;Adam&rsquo;s apple'.</p><p>Clinical examination was normal apart from a palpable lump in the upper neck located slightly to the right of the midline (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Neck ultrasound showed this to be an anvil-shaped, highly vascular homogenous structure measuring 0.9<FONT FACE="arial,helvetica">x</FONT>1.1<FONT FACE="arial,helvetica">x</FONT>1.3 cm, lying at and beneath the level of the base of the tongue (<cross-ref type="fig" refid="F2">figure 2</cross-ref>), and there was non-thyroidal tissue within the thyroid fossa.</p><p>Radioisotope scanning using 13 MBq pertechnetate showed uptake in...]]></description>
<dc:creator><![CDATA[Yeap, P. M., Attaie, M., Jones, J., Maroo, S., Donaldson, M.]]></dc:creator>
<dc:date>2012-01-12T20:21:47-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300773</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300773</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Journalology, Drugs: CNS (not psychiatric), Radiology, Clinical diagnostic tests, Radiology (diagnostics), Screening (epidemiology), Competing interests (ethics), Thyroid disease, Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Visible thyroid ectopia]]></dc:title>
<prism:publicationDate>2012-01-12</prism:publicationDate>
<prism:section>Images in neonatal medicine</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300872v1?rss=1">
<title><![CDATA[National neonatal data to support specialist care and improve infant outcomes]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300872v1?rss=1</link>
<description><![CDATA[<p>&lsquo;Liberating the NHS&rsquo; and the new Outcomes Framework make information central to the management of the UK National Health Service (NHS). The principles of patient choice and government policy on the transparency of outcomes for public services are key drivers for improving the performance. Specialist neonatal care is able to respond positively to these challenges owing to the development of a well-defined dataset and comprehensive national data collection. When combined with analysis, audit and feedback at the national level, this is proving to be an effective means to harness the potential of clinical data. Other key characteristics have been an integrated approach to ensure that data are captured once and serve multiple needs, collaboration between professional organisations, parents, academic institutions, the commercial sector and NHS managers, and responsiveness to changing requirements. The authors discuss these aspects of national neonatal specialist data and point to future developments.</p>]]></description>
<dc:creator><![CDATA[Spencer, A., Modi, N.]]></dc:creator>
<dc:date>2012-01-03T07:12:17-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300872</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300872</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[National neonatal data to support specialist care and improve infant outcomes]]></dc:title>
<prism:publicationDate>2012-01-03</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300929v1?rss=1">
<title><![CDATA[Electrolytes in sick neonates - which sodium is the right answer?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300929v1?rss=1</link>
<description><![CDATA[<sec><st>Introduction</st><p>Hypoproteinaemia leads to spuriously high-sodium values when measured by indirect ion-selective electrodes (ISE) as used in main laboratory analysers compared with direct ISE employed in point-of-care analysers (POCT). The authors, therefore, investigated the occurrence of hypoalbuminaemia and its effect on measured sodium from POCT and the main laboratory analyser of neonatal intensive-care samples.</p></sec><sec><st>Method</st><p>Sodium, in paired retrospective samples, measured by the main laboratory and neonatal unit blood-gas (POCT) analysers were compared.</p></sec><sec><st>Results</st><p>Hypoalbuminaemia (&lt;30 g/l) was present in 1400/2420 paired results. Sodium was higher when measured by laboratory analyser, the difference increased with decreasing albumin; sodium (laboratory &ndash; POCT)=7.6 (&plusmn;1.1)&ndash;0.22 (&plusmn;0.04)<FONT FACE="arial,helvetica">x</FONT>albumin. A difference &gt;3 mmol/l was present in 31% and consequently underestimated (9.4%) hyponatraemia and overestimated (3.8%) hypernatraemia.</p></sec><sec><st>Conclusion</st><p>Hypoalbuminaemia is common in sick neonates and monitoring electrolytes using POCT and laboratory analysers frequently yield significantly different results with consequent misclassification. In these patients, measurement of electrolytes by direct ISE (blood-gas analyser) may be more accurate.</p></sec>]]></description>
<dc:creator><![CDATA[King, R. I., Mackay, R. J., Florkowski, C. M., Lynn, A. M.]]></dc:creator>
<dc:date>2012-01-03T07:12:16-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300929</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300929</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Metabolic disorders]]></dc:subject>
<dc:title><![CDATA[Electrolytes in sick neonates - which sodium is the right answer?]]></dc:title>
<prism:publicationDate>2012-01-03</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301148v1?rss=1">
<title><![CDATA[Are we there yet? Bevacizumab therapy for retinopathy of prematurity]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301148v1?rss=1</link>
<description><![CDATA[<p>The publication of the BEAT-ROP study of bevacizumab (Avastin) treatment for Zone I and II retinopathy of prematurity (ROP) has raised hopes that there might now be a simpler, cheaper and more effective treatment than laser therapy, the current standard of care. However, we would urge caution at this point in time. We review the scientific background to the use of intravitreal anti-vascular endothelial growth factor for ROP, highlight a number of design issues in the BEAT-ROP study and problems with interpretation of the results. For example, no visual outcomes were reported and the study was underpowered to assess longer term safety. Intravitreal bevacizumab leaks into the systemic circulation in animals and adult humans and there are real concerns of potential harm to the developing preterm infant because vascular growth factors play a critical role in organogenesis. We conclude that bevacizumab should be reserved for exceptional circumstances and compassionate use pending further studies. Laser remains the proven effective therapy for first line treatment of all forms of ROP with little systemic morbidity. Neonatology and ophthalmology have an impressive record of conducting collaborative multicentre studies and we urgently need further rigorously designed, adequately powered randomised trials of anti-VEGF agents that evaluate visual outcomes as well as short and long term ocular and systemic safety.</p>]]></description>
<dc:creator><![CDATA[Darlow, B. A., Ells, A. L., Gilbert, C. E., Gole, G. A., Quinn, G. E.]]></dc:creator>
<dc:date>2011-12-30T01:47:56-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301148</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301148</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Are we there yet? Bevacizumab therapy for retinopathy of prematurity]]></dc:title>
<prism:publicationDate>2011-12-30</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-301041v1?rss=1">
<title><![CDATA[Volume-targeted ventilation in infants born at or near term]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-301041v1?rss=1</link>
<description><![CDATA[<sec><st>Objectives</st><p>To determine the impact of different volume-targeted (VT) levels during volume-targeted ventilation (VTV) on the work of breathing (WOB) of infants born at or near term and to investigate whether a level of VT reduced the WOB below that experienced on respiratory support without VT.</p></sec><sec><st>Design</st><p>Prospective crossover study.</p></sec><sec><st>Patients</st><p>Sixteen infants, median gestational age of 38 (range 34&ndash;41) weeks, birth weight of 3.1 (range 1.5&ndash;4.1) kg and postnatal age of 5 (range 2&ndash;17) days were studied. The infants were receiving time-cycled, pressure-limited ventilation in a continuous mandatory or in a triggered mode.</p></sec><sec><st>Interventions</st><p>The infants were studied first without VT (baseline) and then at VT levels of 4, 5 and 6 ml/kg delivered in a random order. After each VT level, the infants were returned to baseline.</p></sec><sec><st>Main outcome measure</st><p>The WOB was assessed by measuring the transdiaphragmatic pressure-time product (PTPdi).</p></sec><sec><st>Results</st><p>One infant became apnoeic at VT of 6 ml/kg. At a VT level of 4 ml/kg, four infants were making such vigorous respiratory efforts that no inflations were delivered. The median PTPdi was higher at a VT level of 4 ml/kg than at 5 ml/kg (p&lt;0.01) or 6 ml/kg (p&lt;0.001). Only at a VT level of 6 ml/kg was the median PTPdi lower than that at baseline (p&lt;0.01).</p></sec><sec><st>Conclusion</st><p>Low VT levels (4 ml/kg) during VTV increase the WOB in ventilated infants born at term or near term. The results suggest that a VT level of 6 ml/kg could be used to reduce the WOB.</p></sec>]]></description>
<dc:creator><![CDATA[Chowdhury, O., Rafferty, G. F., Lee, S., Hannam, S., Milner, A. D., Greenough, A.]]></dc:creator>
<dc:date>2011-12-22T02:02:02-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-301041</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-301041</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Airway biology]]></dc:subject>
<dc:title><![CDATA[Volume-targeted ventilation in infants born at or near term]]></dc:title>
<prism:publicationDate>2011-12-22</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300117v1?rss=1">
<title><![CDATA[The first five inflations during resuscitation of prematurely born infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300117v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To study the first five inflations during the resuscitation of prematurely born infants and whether the infant's inspiratory efforts influenced the expired tidal volume.</p></sec><sec><st>Design</st><p>Prospective observational study.</p></sec><sec><st>Setting</st><p>Two tertiary perinatal centres.</p></sec><sec><st>Patients</st><p>Thirty infants, median gestational age 30 (23&ndash;34) weeks.</p></sec><sec><st>Interventions</st><p>The first five inflations delivered via a face mask and t-piece device were examined using respiratory function monitoring.</p></sec><sec><st>Main outcome measures</st><p>Inflation pressures, inflation times and expiratory volumes were recorded and comparison made of inflations during which the infant made an inspiratory effort (active inflation) or did not (passive inflation).</p></sec><sec><st>Results</st><p>Overall, the median expired tidal volume was 2.5 (0&ndash;19.8) ml/kg and was lower for passive (median 2.1 ml/kg, range 0&ndash;19.8 ml/kg) compared with active (median 5.6 ml/kg, range 1.2&ndash;12.2 ml/kg) inflations (ratio of geometric means 1.85, 95% CI 1.18 to 28%) (p=0.007). Overall, the median face mask leak was 54.5% and was lower for active (34.5%) compared with passive (60.7%) inflations (mean difference in % leak: 12.4%, 95% CI 0.9 to 24%) (p=0.0354). There was a significant positive correlation between the expiratory volumes and the inflation pressures (R2 between subjects 0.19, p=0.04) and a negative correlation between the expiratory tidal volumes and the face mask leaks (R2 between subjects=0.051, p&lt;0.001), but there was no significant correlation between the inflation times and the expiratory tidal volumes.</p></sec><sec><st>Conclusion</st><p>The expired tidal volume, inflation pressures and times during the first five inflations during resuscitation were variable. The expired tidal volumes were significantly greater if the infant inspired during the inflation.</p></sec>]]></description>
<dc:creator><![CDATA[Murthy, V., Dattani, N., Peacock, J. L., Fox, G. F., Campbell, M. E., Milner, A. D., Greenough, A.]]></dc:creator>
<dc:date>2011-12-15T00:31:08-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300117</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300117</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Airway biology, Resuscitation]]></dc:subject>
<dc:title><![CDATA[The first five inflations during resuscitation of prematurely born infants]]></dc:title>
<prism:publicationDate>2011-12-15</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300822v1?rss=1">
<title><![CDATA[Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300822v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>Culture of percutaneous central venous line (PCVL) segments may assist the diagnosis of line colonisation and catheter-related sepsis (CRS). The authors aimed to determine if the diagnosis of CRS and colonisation of PCVLs in neonates is improved by the culture of the proximal and middle segments of the line in addition to the tip.</p></sec><sec><st>Patients and methods</st><p>In a prospective study, proximal, middle and tip segments of PCVLs indwelling for more than 24 h in term and preterm infants were sent for culture at line removal. Definite CRS was considered as a positive peripheral blood culture plus any line segment growing the same organism in an infant with clinical signs of sepsis.</p></sec><sec><st>Results</st><p>189 lines were removed from 143 neonates: 142 (75%) were from well infants and 47 (25%) were from neonates with suspected clinical sepsis. The overall CRS rate was 7.9% (15 of 189 line episodes). In well infants, bacterial colonisation rates were significantly higher for proximal segments than for tips (p=0.004). Comparative rates of segmental culture positivity and their positive predictive values for definite CRS were similar for all segments. The diagnosis of CRS was not improved beyond a sole line tip culture by additional middle or proximal segmental cultures or by combinations of the three segments.</p></sec><sec><st>Conclusion</st><p>In well infants, the proximal segments of PCVLs were more often colonised than line tips, but in clinically septic infants preferential culture of proximal or middle segments or combinations of the three segments did not permit better prediction of definite CRS than the culture of the line tip alone. Further studies prior to antibiotic therapy are indicated in babies with suspected CRS.</p></sec>]]></description>
<dc:creator><![CDATA[Ponnusamy, V., Venkatesh, V., Curley, A., Musonda, P., Brown, N., Tremlett, C., Clarke, P.]]></dc:creator>
<dc:date>2011-12-15T00:31:08-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300822</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300822</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Oncology, Drugs: infectious diseases, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Segmental percutaneous central venous line cultures for diagnosis of catheter-related sepsis]]></dc:title>
<prism:publicationDate>2011-12-15</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300336v1?rss=1">
<title><![CDATA[Compressive force applied to a manikin's head during mask ventilation]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300336v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To investigate the compressive force applied to the head during mask ventilation and determine whether this force increases in response to an attempt to correct the mask leak.</p></sec><sec><st>Methods</st><p>The authors asked 24 participants (consultants, fellows and nurses) to administer positive pressure ventilation to a modified leak-free, term newborn manikin using a self-inflating bag (SIB) and a Neopuff T-piece device. Recordings were made before and after the participants were informed about their percentage of mask leak and asked to correct this. Airway pressure and flow were measured using a Florian monitor, and the force applied to the head was measured using a concealed custom-made load cell weighing scale.</p></sec><sec><st>Results</st><p>There were no differences in the mean (SD) force applied to the head between devices used and before or after the attempt to correct the mask leak (SIB before 2215 (892) and after 2195 (989) g; Neopuff before 1949 (957) and after 2028 (909) g). There was a large variation in force with both devices before and after the attempt (coefficient of variation: SIB before 40% and after 45%; Neopuff before 50% and after 45%). There was no correlation between mask leak and the difference in force used before and after the attempt to correct the mask leak using both devices.</p></sec><sec><st>Conclusion</st><p>During mask ventilation of a manikin, the authors observed that large forces were exerted on the head with either an SIB or a Neopuff, but these forces did not increase during the attempt to minimise the mask leak.</p></sec>]]></description>
<dc:creator><![CDATA[van Vonderen, J. J., Kleijn, T. A., Schilleman, K., Walther, F. J., Hooper, S. B., te Pas, A. B.]]></dc:creator>
<dc:date>2011-12-05T22:54:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300336</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300336</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Compressive force applied to a manikin's head during mask ventilation]]></dc:title>
<prism:publicationDate>2011-12-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300601v1?rss=1">
<title><![CDATA[Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300601v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare the effects of metoclopramide and domperidone on the breast milk output of mothers with infants in neonatal intensive care.</p></sec><sec><st>Design</st><p>Double-blind randomised controlled trial.</p></sec><sec><st>Setting</st><p>Tertiary level neonatal intensive care unit (NICU).</p></sec><sec><st>Sample</st><p>Eighty mothers expressing breast milk for their infants (mean gestational age 28 weeks) based in NICU and the amounts expressed fell short of the prescribed target.</p></sec><sec><st>Intervention</st><p>Mothers were randomised to receive domperidone or metoclopramide for 10 days (10 mg three times a day).</p></sec><sec><st>Outcome measures</st><p>Total milk volume daily for up to 10 days before the medication, 10 days during the trial and up to 10 days after medication. Adverse side effects were also recorded.</p></sec><sec><st>Results</st><p>Mothers produced more milk in the domperidone group and achieved a mean of 96.3% increase in milk volume (mean increase/pretrial volume) compared with a 93.7% increase for metoclopramide. After adjusting for the amount of milk produced prior to medication, the mean amount of milk produced while taking medication for those on domperidone was 31.0 ml/24 h (95% CI &ndash;5.67 to 67.6) greater than the mean for those on metoclopramide. Seven mothers taking metoclopramide reported side effects and three taking domperidone; a further eight women (of 29) who had a follow-on prescription for metoclopramide also reported side effects.</p></sec><sec><st>Conclusions</st><p>Oral domperidone and metoclopramide increased the volume of milk produced by mothers who are expressing to feed their babies in NICU. There were small differences in milk output between the two medications and in the incidence of side effects, but the differences were non-significant.</p></sec>]]></description>
<dc:creator><![CDATA[Ingram, J., Taylor, H., Churchill, C., Pike, A., Greenwood, R.]]></dc:creator>
<dc:date>2011-12-05T22:54:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300601</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300601</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Clinical trials (epidemiology), Childhood nutrition, Reproductive medicine, Child health, Infant nutrition (including breastfeeding), Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial]]></dc:title>
<prism:publicationDate>2011-12-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300532v1?rss=1">
<title><![CDATA[Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300532v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To compare the efficacy and safety of oral versus intravenous ibuprofen for the pharmacological closure of patent ductus arteriosus (PDA) in less mature preterm infants.</p></sec><sec><st>Design</st><p>Prospective, randomised controlled study.</p></sec><sec><st>Setting</st><p>Tertiary neonatal intensive care unit.</p></sec><sec><st>Patients and interventions</st><p>The study enrolled 80 preterm infants with gestational age &le;28 weeks, birth weight &lt;1000 g, postnatal age 48 to 96 h, and had echocardiographically confirmed significant PDA. Seventy extremely low birthweight (ELBW) preterm infants received either intravenous or oral ibuprofen randomly as an initial dose of 10 mg/kg, followed by 5 mg/kg at 24 and 48 h.</p></sec><sec><st>Main outcome measures</st><p>The success rate and the safety of the drugs in ELBW preterm infants were the major outcomes.</p></sec><sec><st>Results</st><p>PDA closure rate was significantly higher with oral ibuprofen (83.3% vs 61.7%) after the first course of the treatment (p=0.04). Although the primary closure rate was marginally higher in the oral ibuprofen group, the need for a second course of ibuprofen during the whole hospitalisation was similar between groups: 11 of 36 in oral versus 15 of 34 in intravenous groups (p=0.24) because of a higher reopening rate in the oral group. In addition to no increase in side effects with oral ibuprofen use, the need for postnatal steroid use for chronic lung disease was significantly lower in oral ibuprofen group (p=0.001).</p></sec><sec><st>Conclusions</st><p>Oral ibuprofen is as effective as intravenous ibuprofen for PDA closure even in ELBW infants.</p></sec>]]></description>
<dc:creator><![CDATA[Erdeve, O., Yurttutan, S., Altug, N., Ozdemir, R., Gokmen, T., Dilmen, U., Oguz, S. S., Uras, N.]]></dc:creator>
<dc:date>2011-12-05T22:54:27-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300532</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300532</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Congenital heart disease, Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants]]></dc:title>
<prism:publicationDate>2011-12-05</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300548v1?rss=1">
<title><![CDATA[Neonatal resuscitation: are your trainees performing as you think they are? A retrospective review of a structured resuscitation assessment for neonatal medical trainees over an 8-year period]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300548v1?rss=1</link>
<description><![CDATA[<sec><st>Objective</st><p>To ascertain whether Newborn Life Support Course (NLS) accredited trainees could demonstrate resuscitation skills appropriate to their level of training by providing standardised assessments of both junior and senior paediatric trainees during their induction period.</p></sec><sec><st>Design</st><p>Retrospective review of medical staff resuscitation assessments over an 8-year period from 2003 to 2010.</p></sec><sec><st>Setting</st><p>A network-lead tertiary neonatal service with over 11 000 deliveries annually.</p></sec><sec><st>Participants</st><p>Neonatal medical staff: junior (speciality trainee(ST) of years 1&ndash;3) and senior trainees (ST 4&ndash;8 with tier 2 on-call responsibilities).</p></sec><sec><st>Intervention</st><p>A standardised criterion-referenced assessment was performed by two NLS instructors. Junior trainee assessment focused on the basic airway skills learnt on an NLS course. Senior trainees demonstrated resuscitation of a baby with meconium-stained liquor, focusing on advanced life support, including intubation of the mannequin.</p></sec><sec><st>Main outcome measures</st><p>Assessment outcomes were pass/fail; fails were categorised as algorithm failure, technical skills failure or both. For trainees who failed the first assessment, the outcome of the second assessment following appropriate feedback was recorded.</p></sec><sec><st>Results</st><p>Two hundred and sixty-two assessments were performed: 160 junior and 102 senior trainees; 98/160 (61%) of junior and 57/102 (56%) of senior trainees passed their first assessment; 69% of junior trainees who failed the first assessment had a second assessment recorded. There was a 79% pass rate at second assessment; 89% of senior trainees who failed a first assessment had a second assessment recorded. There was an 85% pass rate at second assessment. The majority of trainees who failed an assessment had problems with both the resuscitation algorithm and technical skills.</p></sec><sec><st>Conclusions</st><p>Significant numbers of trainees who have been formally trained in neonatal resuscitation skills previously do not pass the standardised resuscitation assessment, thus require an additional input to maintain their competence in neonatal resuscitation.</p></sec>]]></description>
<dc:creator><![CDATA[Cusack, J., Fawke, J.]]></dc:creator>
<dc:date>2011-11-17T22:01:13-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300548</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300548</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Resuscitation]]></dc:subject>
<dc:title><![CDATA[Neonatal resuscitation: are your trainees performing as you think they are? A retrospective review of a structured resuscitation assessment for neonatal medical trainees over an 8-year period]]></dc:title>
<prism:publicationDate>2011-11-17</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300627v1?rss=1">
<title><![CDATA[Early-onset group B Streptococcal sepsis: new recommendations from the Centres for Disease Control and Prevention]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300627v1?rss=1</link>
<description><![CDATA[<p>Since the early 1970s, group B Streptococcus (GBS) has been the leading cause of early-onset neonatal sepsis in the United States and many countries worldwide.<cross-ref type="bib" refid="R1">1</cross-ref> <cross-ref type="bib" refid="R2">2</cross-ref> Although the gastrointestinal tract is the primary source of genital colonisation, 10&ndash;30 per cent of women are colonised with GBS in their birth canal.<cross-ref type="bib" refid="R3">3</cross-ref> Pregnant women with GBS colonisation are 25 times more likely to deliver an infant with early-onset GBS sepsis than women who are culture negative.<cross-ref type="bib" refid="R4">4</cross-ref> Affected infants become colonised/infected during labour and delivery and present with respiratory distress or other signs of sepsis in the first 24&ndash;48 h of life. In 1996, the Centres for Disease Control in collaboration with representatives from the major physician organisations published initial recommendations for the prevention of early-onset GBS disease.<cross-ref type="bib" refid="R5">5</cross-ref> Those recommendations were modified in 2002 when universal screening of all pregnant women at 35&ndash;37...]]></description>
<dc:creator><![CDATA[Randis, T. M., Polin, R. A.]]></dc:creator>
<dc:date>2011-11-04T05:11:59-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300627</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300627</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Obstetrics and gynaecology, Immunology (including allergy), Drugs: infectious diseases, Pregnancy, Reproductive medicine, Screening (epidemiology), Screening (public health)]]></dc:subject>
<dc:title><![CDATA[Early-onset group B Streptococcal sepsis: new recommendations from the Centres for Disease Control and Prevention]]></dc:title>
<prism:publicationDate>2011-11-04</prism:publicationDate>
<prism:section>Guideline reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300121v1?rss=1">
<title><![CDATA[DTI reveals network injury in perinatal stroke]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300121v1?rss=1</link>
<description><![CDATA[<sec><st>Background</st><p>Previous research showed acute diffusion-weighted imaging changes in pulvinar after extensive cortical injury from neonatal stroke. The authors used diffusion tensor imaging (DTI) to see how separate regions of ipsilateral thalamus are directly affected after a primary hit to their connected cortex in neonatal stroke.</p></sec><sec><st>Methods</st><p>The authors analysed DTI images of three term infants with acute unilateral cortical arterial ischaemic stroke. Probabilistic tractography was used to define separate thalamic regions of interests (ROIs). The authors evaluated the three eigenvalues (EV) and apparent diffusion coefficient (ADC) values in the ROIs.</p></sec><sec><st>Results</st><p>The ADC and EV in voxels of ROIs placed within the nuclei corresponding to ischaemic cortex were significantly lower than those in the unaffected contralesional thalamic nuclei.</p></sec><sec><st>Conclusions</st><p>Our findings support the concept of acute network injury in neonatal stroke. ADC and EV were altered in specific thalamic regions that corresponded to the specific cortical areas affected by the primary ischaemic injury.</p></sec>]]></description>
<dc:creator><![CDATA[Dudink, J., Counsell, S. J., Lequin, M. H., Govaert, P. P.]]></dc:creator>
<dc:date>2011-10-20T05:25:25-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300121</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300121</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Stroke, Radiology, Clinical diagnostic tests, Radiology (diagnostics)]]></dc:subject>
<dc:title><![CDATA[DTI reveals network injury in perinatal stroke]]></dc:title>
<prism:publicationDate>2011-10-20</prism:publicationDate>
<prism:section>Short research reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300573v1?rss=1">
<title><![CDATA[The state of neonatal transport services in the UK]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300573v1?rss=1</link>
<description><![CDATA[<p>Neonatal transfer services across the UK have evolved at different rates, using a variety of approaches. Scotland, Northern Ireland and most recently Wales have adopted a more centralised approach than in England, where due to comparative population size transport services have developed alongside neonatal network boundaries. Despite considerable investment, transport provision remains variable in some areas and there are continuing issues common to most regions, including service provision and configuration, training, competencies and audit. Further development is required to optimise the use of available resources and develop benchmarking to ensure a high quality sustainable service.</p>]]></description>
<dc:creator><![CDATA[Fenton, A. C., Leslie, A.]]></dc:creator>
<dc:date>2011-09-26T03:42:45-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300573</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300573</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The state of neonatal transport services in the UK]]></dc:title>
<prism:publicationDate>2011-09-26</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.300492v1?rss=1">
<title><![CDATA[Milk osmolality: does it matter?]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.300492v1?rss=1</link>
<description><![CDATA[<p>High osmolality of infant feed reflects a high concentration of solute particles and has been implicated as a cause of necrotising enterocolitis. Evidence for direct intestinal mucosal injury as a result of hyperosmolar feeds is scant, and no good evidence has been found to support such an association. High osmolality of enteral substrate may, however, slow down gastric emptying. Osmolality of current infant feeds ranges from around 300 mOsm/kg in human breast milk to just more than 400 mOsm/kg in fully fortified breast milk. Addition of mineral and vitamin supplements to small volumes of milk can increase osmolality significantly and should be avoided if possible.</p>]]></description>
<dc:creator><![CDATA[Pearson, F., Johnson, M. J., Leaf, A. A.]]></dc:creator>
<dc:date>2011-09-19T07:25:37-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.300492</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.300492</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Milk osmolality: does it matter?]]></dc:title>
<prism:publicationDate>2011-09-19</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300641v1?rss=1">
<title><![CDATA[What are the main research findings during the last 5 years that have changed my approach to clinical practice?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300641v1?rss=1</link>
<description><![CDATA[
<p>When asked to address the above question, findings that appeared to be among the most relevant included (1) interventions in the delivery room directed at supporting the physiological transition from intrauterine to extrauterine life rather than actively intervening in it; (2) recent data suggesting that keeping extremely low-gestational age neonates at a pulse oximeter saturation (SpO<SUB>2</SUB>) of 91&ndash;95% would increase their chances of survival compared with aiming for lower SpO<SUB>2</SUB> values; (3) using caffeine citrate in infants &lt;1250 g with apnoea of prematurity improves neurodevelopmental outcome; (4) injecting antivascular epithelial growth factor into the vitreous seems to be an effective treatment for retinopathy of prematurity and (5) moderate hypothermia for perinatal hypoxic-ischaemic encephalopathy increases the likelihood of survival without neurological impairment. Here, data that support these recent changes in approach will be presented and discussed.</p>
]]></description>
<dc:creator><![CDATA[Poets, C. F.]]></dc:creator>
<dc:date>2011-08-24T09:36:47-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300641</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300641</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[What are the main research findings during the last 5 years that have changed my approach to clinical practice?]]></dc:title>
<prism:publicationDate>2011-08-24</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/archdischild-2011-300535v1?rss=1">
<title><![CDATA[Born just a few weeks early: does it matter?]]></title>
<link>http://fn.bmj.com/cgi/content/short/archdischild-2011-300535v1?rss=1</link>
<description><![CDATA[
<p>Until recently, infants born at moderate preterm (32&ndash;33 weeks) and late preterm (34&ndash;36 weeks) gestations have gone largely unstudied. Since their outcomes were thought to be similar to those of infants born at 37 weeks and above, they have historically been managed in much the same way as infants born at term. However, accumulating data indicate that risks of morbidity and mortality are significantly greater in this group than previously believed. Since moderate and late preterm infants account for around 6% of all births, very large numbers of babies are potentially affected. Although their problems may be less obvious than those of extremely preterm infants, the population impact of long-term health and neurodevelopmental problems in this group will be substantial. This review summarises the current available literature, highlights gaps in knowledge and discusses the implications of late preterm birth for both clinical practice and research in the perinatal period and beyond.</p>
]]></description>
<dc:creator><![CDATA[Boyle, J. D., Boyle, E. M.]]></dc:creator>
<dc:date>2011-08-24T09:36:46-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2011-300535</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;archdischild-2011-300535</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Born just a few weeks early: does it matter?]]></dc:title>
<prism:publicationDate>2011-08-24</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.209700v1?rss=1">
<title><![CDATA[How reliably can paediatric professionals identify pale stool from cholestatic newborns?]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.209700v1?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>The success of surgery in infants with hepatobiliary disease is inversely proportional to the age when surgery was performed. Pale stool colour is a major indicator of biliary obstruction. However, simple recognition has been inadequate, resulting in late diagnosis and referral.</p>
<p>Objective To assess the skills of healthcare professionals in recognising pale stools.</p>
</sec>
<sec><st>Method</st>
<p>Photographs of normal, acholic and indeterminate infant stools were shown to paediatric professionals who have regular contact with jaundiced babies at three London teaching hospitals. Each stool was classified as &lsquo;healthy&rsquo; or &lsquo;suspect&rsquo;.</p>
</sec>
<sec><st>Results</st>
<p>One-third of the stools were not correctly identified by physicians and nurses.</p>
</sec>
<sec><st>Conclusion</st>
<p>Experienced professionals often do not recognise stool colour associated with biliary obstruction. The authors propose that stool colour cards similar to those used in Japan and Taiwan may improve early detection of hepatobiliary disease at a minimal cost.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Bakshi, B., Sutcliffe, A., Akindolie, M., Vadamalayan, B., John, S., Arkley, C., Griffin, L. D., Baker, A.]]></dc:creator>
<dc:date>2011-08-17T20:02:21-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.209700</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.209700</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[How reliably can paediatric professionals identify pale stool from cholestatic newborns?]]></dc:title>
<prism:publicationDate>2011-08-17</prism:publicationDate>
<prism:section>Guideline reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.196451v1?rss=1">
<title><![CDATA[Neonatal stroke]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.196451v1?rss=1</link>
<description><![CDATA[
<p>Neonatal stroke encompasses a range of focal and multifocal ischaemic and haemorrhagic tissue injuries. This review will concentrate on focal brain injury that occurs as a consequence of arterial infarction, most frequently the left middle cerebral artery, or more rarely as a consequence of cerebral sinus venous thrombosis (CSVT). Both conditions are multifactorial in origin. The incidence of both acquired and genetic thrombophilic disorders in both mothers and infants is high although rarely causal in isolation. Neurodevelopmental morbidity occurs in over 50% of children. Specific therapy in the form of anticoagulation is currently only recommended in CSVT and needs to be carefully monitored in the presence of haemorrhage.</p>
]]></description>
<dc:creator><![CDATA[Rutherford, M. A., Ramenghi, L. A., Cowan, F. M.]]></dc:creator>
<dc:date>2011-08-17T20:02:23-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.196451</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.196451</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Neonatal stroke]]></dc:title>
<prism:publicationDate>2011-08-17</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.210856v1?rss=1">
<title><![CDATA[Actuarial day-by-day survival rates of preterm infants admitted to neonatal intensive care in New South Wales and the Australian Capital Territory]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.210856v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To characterise the actuarial day-by-day survival of premature infants in a geographically defined population.</p>
</sec>
<sec><st>Setting</st>
<p>10 Neonatal Intensive Care Units (NICUs) in New South Wales (NSW) and Australian Capital Territory (ACT), Australia.</p>
</sec>
<sec><st>Design</st>
<p>Retrospective analysis of prospectively collected data as part of NICUs' data collection in NSW and ACT.</p>
</sec>
<sec><st>Subjects</st>
<p>Premature infants born at 22<sup>+0</sup> to 31<sup>+6</sup> weeks' gestation between January 1997 and December 2006 and admitted to one of the 10 NICUs in NSW and ACT.</p>
</sec>
<sec><st>Outcome</st>
<p>Actuarial day-by-day survival to discharge from NICU.</p>
</sec>
<sec><st>Results</st>
<p>Survival to discharge after initiation of neonatal intensive care ranges from 30.0% at 23 weeks' gestation to 98.8% at 31 weeks. Actuarial day-by-day survival increased across all gestations. This improvement was most notable among the babies who were born &lt;26 weeks gestation.</p>
</sec>
<sec><st>Conclusion</st>
<p>Preterm infants who survive the first few postnatal days have considerable chances of long-term survival. It is important to revise the information stored regarding chances of survival so it covers chances at regular intervals, especially after the first few days of life.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Abdel-Latif, M. E., Kecskes, Z., Bajuk, B., On behalf of the NSW and the ACT Neonatal Intensive Care Audit Group]]></dc:creator>
<dc:date>2011-08-09T23:56:06-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.210856</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.210856</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal and paediatric intensive care, Neonatal health, Neonatal intensive care]]></dc:subject>
<dc:title><![CDATA[Actuarial day-by-day survival rates of preterm infants admitted to neonatal intensive care in New South Wales and the Australian Capital Territory]]></dc:title>
<prism:publicationDate>2011-08-09</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.214239v1?rss=1">
<title><![CDATA[Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.214239v1?rss=1</link>
<description><![CDATA[
<p>Selective serotonin reuptake inhibitors (SSRIs) are increasingly used during pregnancy and lactation, with 1.8&ndash;2.8% exposed pregnancies. Given the risks of untreated maternal depression for both mother and child, adequate treatment is essential. If pharmacological treatment with SSRIs is indicated, the fetal and neonatal effects of SSRIs have to be considered, as SSRIs cross the placenta and are excreted into breast milk. The overall risk of major congenital malformations during SSRI exposure in the first trimester does not appear to be greatly increased. Depending on the variability in pharmacokinetic properties between the different SSRIs and the individual drug metabolism of mother and child, SSRI exposure during late pregnancy can lead to serotonin reuptake inhibitor-related symptoms in up to 30% of exposed infants postnatally. Symptoms are generally mild and self-limited, but need observation during at least 48 h as some infants develop severe symptoms needing intervention. Limited data are available about the long-term neurodevelopmental outcomes after SSRI exposure during pregnancy and lactation, but currently, cognitive development seems normal, while behavioural abnormalities may be increased.</p>
<p>In this article, the available clinical data are reviewed. Additionally, the authors provide a multidisciplinary guideline for the monitoring and management of neonates exposed to SSRIs during pregnancy and lactation.</p>
]]></description>
<dc:creator><![CDATA[Sie, S. D., Wennink, J. M. B., van Driel, J. J., te Winkel, A. G. W., Boer, K., Casteelen, G., van Weissenbruch, M. M.]]></dc:creator>
<dc:date>2011-07-27T22:28:05-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.214239</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.214239</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation]]></dc:title>
<prism:publicationDate>2011-07-27</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.199703v1?rss=1">
<title><![CDATA[Delayed cord clamping and blood flow in the superior vena cava in preterm infants: an observational study]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.199703v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To determine if timing of cord clamping affects blood flow in the upper body, as measured by flow in the superior vena cava (SVC).</p>
</sec>
<sec><st>Design</st>
<p>Observational study.</p>
</sec>
<sec><st>Setting</st>
<p>Neonatal Unit, Middlemore Hospital, Auckland, New Zealand.</p>
</sec>
<sec><st>Patients</st>
<p>30 preterm infants &lt;30 weeks' gestational age.</p>
</sec>
<sec><st>Intervention</st>
<p>Cord clamping was immediate in 17 infants and delayed by 30&ndash;45 s in 13.</p>
</sec>
<sec><st>Results</st>
<p>Infants in the two groups did not differ significantly in terms of gestational age, gender or use of antenatal steroids. Median flow in the SVC in the first 24 h was significantly higher in the group with delayed clamping (median 91 ml/kg/min; IQR 81&ndash;101) compared with 52 ml/kg/min (IQR 42&ndash;100) in the immediate clamping group (p=0.028). Fewer infants in the delayed group had low flow (1 compared with 9; p=0.017). All three infants with intraventricular haemorrhage (IVH) (of any grade) had low flow.</p>
</sec>
<sec><st>Conclusions</st>
<p>Blood flow in the SVC was higher in infants where delayed cord clamping was performed. The relationship of IVH, low flow and timing of cord clamping requires further study.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Meyer, M. P., Mildenhall, L.]]></dc:creator>
<dc:date>2011-05-17T02:07:50-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.199703</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.199703</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:subject><![CDATA[Child health, Infant health, Neonatal health]]></dc:subject>
<dc:title><![CDATA[Delayed cord clamping and blood flow in the superior vena cava in preterm infants: an observational study]]></dc:title>
<prism:publicationDate>2011-05-17</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.207043v1?rss=1">
<title><![CDATA[Which growth criteria better predict fetal programming?]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.207043v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To test whether customised (ct) growth criteria are more reliable than standard (st) ones to predict intrauterine insult.</p>
</sec>
<sec><st>Patients</st>
<p>32 mothers and their singleton term neonates selected as small for gestational age (st-SGA=8) or appropriate for gestational age (st-AGA=24).</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Nitric oxide, high-sensitive C reactive protein (hs-CRP), uric acid, blood lipids and protein levels were analysed in maternal and cord blood.</p>
</sec>
<sec><st>Results</st>
<p>Applying customised criteria yielded 16 ct-AGA, 13 ct-SGA and 3 ct-LGA (large for gestational age) babies. Both st-SGA and ct-SGA babies had higher nitric oxide and hs-CRP levels. Their mothers had lower albumin fractions. st-SGA babies also had higher triglyceride and cholesterol levels. ct-LGA babies and mothers had higher uric acid levels, and the mothers had higher triglyceride levels.</p>
</sec>
<sec><st>Conclusions</st>
<p>Customised growth criteria better identify babies submitted to unfavourable intrauterine environments. The authors suggest that combined with maternal biochemistry, these growth criteria can be used to screen for adverse <I>fetal programming</I>.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Mattos, S. S., Chaves, M. E. C., Costa, S. M. R., Ishigami, A. C. M., Rego, S. B., Souto Maior, V., Severi, R., de Lima Filho, J. L.]]></dc:creator>
<dc:date>2011-03-27T23:30:09-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.207043</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.207043</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Which growth criteria better predict fetal programming?]]></dc:title>
<prism:publicationDate>2011-03-27</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.208868v1?rss=1">
<title><![CDATA[Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.208868v1?rss=1</link>
<description><![CDATA[
<p>Postnatal steroids have been widely used to facilitate the extubation of ventilator-dependent preterm infants. Reports published in the late 1990s and early 2000s raised concerns about their long-term impact on neurodevelopmental outcomes. Since then, postnatal steroid use has declined sharply, but they continue to be regarded by many clinicians as an essential part of neonatal care, and there is considerable confusion as to the most appropriate time to use them. This review examines the meta-analyses of the relationship between intravenous postnatal steroids and neurodevelopmental impairment, and provides recommendations for their use based upon that body of evidence.</p>
]]></description>
<dc:creator><![CDATA[Yates, H., Newell, S.]]></dc:creator>
<dc:date>2011-03-22T01:51:49-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.208868</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.208868</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Postnatal intravenous steroids and long-term neurological outcome: recommendations from meta-analyses]]></dc:title>
<prism:publicationDate>2011-03-22</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.194100v1?rss=1">
<title><![CDATA[Procalcitonin in detecting neonatal nosocomial sepsis]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.194100v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To investigate the accuracy of procalcitonin (PCT) as a diagnostic marker of nosocomial sepsis (NS) and define the most accurate cut-off to distinguish infected from uninfected neonates.</p>
</sec>
<sec><st>Setting</st>
<p>Six neonatal intensive care units (NICUs).</p>
</sec>
<sec><st>Patients</st>
<p>762 neonates admitted to six NICUs during a 28-month observational study for whom at least one serum sample was taken on admission.</p>
</sec>
<sec><st>Main outcome measures</st>
<p>Positive and negative predictive values at different PCT cut-off levels.</p>
</sec>
<sec><st>Results</st>
<p>The overall probability of an NS was doubled or more if PCT was &gt;0.5 ng/ml. In very-low-birth-weight (VLBW) infants, a cut-off of &gt;2.4 ng/ml gave a positive predictive value of NS near to 50% with a probability of a false-positive diagnosis of NS in about 10% of the patients.</p>
</sec>
<sec><st>Conclusions</st>
<p>In VLBW neonates, a serum PCT value &gt;2.4 ng/ml prompts early empirical antibiotic therapy, while in normal-birth-weight infants, a PCT value &le;2.4 ng/ml carries a low risk of missing an NS.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Auriti, C., Fiscarelli, E., Ronchetti, M. P., Argentieri, M., Marrocco, G., Quondamcarlo, A., Seganti, G., Bagnoli, F., Buonocore, G., Serra, G., Bacolla, G., Mastropasqua, S., Mari, A., Corchia, C., Prencipe, G., Piersigilli, F., Rava, L., Di Ciommo, V.]]></dc:creator>
<dc:date>2011-03-15T02:01:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.194100</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.194100</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Procalcitonin in detecting neonatal nosocomial sepsis]]></dc:title>
<prism:publicationDate>2011-03-15</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.170910v1?rss=1">
<title><![CDATA[Promoting growth for preterm infants following hospital discharge]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.170910v1?rss=1</link>
<description><![CDATA[
<p>Preterm infants, especially very preterm infants, are usually growth-restricted at the time of hospital discharge. Proposed interventions to promote catch-up growth following hospital discharge include multinutrient fortification of expressed breast milk for breastfed infants and nutrient-enriched formula milk for formula-fed infants. The current evidence to support these strategies is limited. Fortification of expressed breast milk may increase weight gain and skeletal and head growth during infancy, but more research is needed to define which nutrients confer most benefit, and which population of infants is likely to receive most benefit. Trials that have assessed feeding preterm infants with commercially available nutrient-enriched formula milk (&lsquo;preterm&rsquo; or &lsquo;postdischarge&rsquo; formulae) compared with standard formula milk have not found consistent evidence of an effect on growth parameters or development, probably because ad libitum fed infants reduce their intake relative to the calorie-density of the milk. Future studies should focus on the effect of formulae enriched with protein and minerals rather than energy and assess the effect on lean mass and skeletal growth.</p>
]]></description>
<dc:creator><![CDATA[Morgan, J. A., Young, L., McCormick, F. M., McGuire, W.]]></dc:creator>
<dc:date>2011-03-15T02:01:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.170910</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.170910</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Promoting growth for preterm infants following hospital discharge]]></dc:title>
<prism:publicationDate>2011-03-15</prism:publicationDate>
<prism:section>Reviews</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2011.211649v1?rss=1">
<title><![CDATA[Provision of servo-controlled cooling during neonatal transport]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2011.211649v1?rss=1</link>
<description><![CDATA[
<sec><st>Introduction</st>
<p>Therapeutic hypothermia is a time critical intervention for infants who have experienced a hypoxic&ndash;ischaemic event. Previously reported methods of cooling during transport do not demonstrate the same stability achieved in the neonatal unit. The authors developed a system which allowed provision of servo-controlled cooling throughout transport, and present their first year's experience.</p>
</sec>
<sec><st>Methods</st>
<p>Retrospective review of routinely collected patient data.</p>
</sec>
<sec><st>Results</st>
<p>14 out-born infants were referred for cooling during a 12-month period. Nine infants were managed with the servo-controlled system during transport. Cooling was commenced in all infants before 6 h of life. Median time from team arrival to the infant having a temperature in the target range (33&ndash;34&deg;C) was 45 min. Median temperature during transfer was 33.5&deg;C (range 33&ndash;34&deg;C). Temperature on arrival at the cooling centre ranged from 33.4&deg;C to 33.8&deg;C.</p>
</sec>
<sec><st>Conclusion</st>
<p>Servo-controlled cooling during transport is feasible and provides an optimal level of thermal control.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Johnston, E. D., Becher, J.-C., Mitchell, A. P., Stenson, B. J.]]></dc:creator>
<dc:date>2011-03-06T03:58:23-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2011.211649</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2011.211649</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Provision of servo-controlled cooling during neonatal transport]]></dc:title>
<prism:publicationDate>2011-03-06</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2010.188359v1?rss=1">
<title><![CDATA[Postnatal ultrasound reliability in cerebellar vermis assessment]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2010.188359v1?rss=1</link>
<description><![CDATA[
<sec><st>Background</st>
<p>Cerebellar growth in late gestation is impeded by prematurity which may adversely affect neurocognitive development. Assessment of cerebellar growth should be easily attainable, reliable and reproducible.</p>
</sec>
<sec><st>Objective</st>
<p>To assess the reliability of linear sonographic cerebellar vermis measurement.</p>
</sec>
<sec><st>Method</st>
<p>Cranial ultrasounds of 110 infants ranging from 24 to 41 weeks' gestation were retrospectively reviewed. Cerebellar vermian height, craniocaudal diameter and superior and inferior vermis widths were independently measured on the first midline sagittal image by three neonatal sonologists of varying experience. Interobserver and intraobserver reliability were calculated using the intraclass correlation coefficient (ICC) (2 way mixed model, SPSS V.15.0).</p>
</sec>
<sec><st>Results</st>
<p>61 images were technically adequate. Interobserver ICCs (95% CI) were: cerebellar vermian height 0.88 (0.82 to 0.92); craniocaudal diameter 0.91 (0.86 to 0.94); superior vermis width 0.84 (0.77 to 0.89); inferior vermis width 0.92 (0.89 to 0.95). Intraobserver ICCs were similar.</p>
</sec>
<sec><st>Conclusion</st>
<p>With adequate images, linear ultrasound measurements of cerebellar vermis are reliable.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Armstrong, R. K., Fox, L. M., Cheong, J. L. Y., Davis, P. G., Rogerson, S. K.]]></dc:creator>
<dc:date>2011-01-17T04:15:52-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2010.188359</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2010.188359</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Postnatal ultrasound reliability in cerebellar vermis assessment]]></dc:title>
<prism:publicationDate>2011-01-17</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.175109v1?rss=1">
<title><![CDATA[Assessment of myocardial function in neonates using tissue Doppler imaging]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.175109v1?rss=1</link>
<description><![CDATA[
<sec><st>Objective</st>
<p>To measure the left and right ventricular myocardial velocities using tissue Doppler imaging (TDI) in the first 24 h of life in neonates.</p>
</sec>
<sec><st>Design</st>
<p>Left and right ventricular peak systolic (S'), early diastolic (E') and late diastolic (A') myocardial velocities were measured using TDI alongside standard echocardiography (including peak diastolic atrioventricular flow, E). E/E' ratio was calculated for both ventricles.</p>
</sec>
<sec><st>Setting</st>
<p>UK neonatal intensive care unit.</p>
</sec>
<sec><st>Patients</st>
<p>43 neonates were prospectively recruited into three groups: term (n=16), preterm (30&ndash;36 weeks, n=12) and very preterm (&lt;30 weeks, n=15).</p>
</sec>
<sec><st>Results</st>
<p>Myocardial velocities increased with increasing gestation. Right ventricular velocities were significantly greater than left. E/E' ratio decreased with increasing gestation. Left E/E' ratio was higher than right in each group.</p>
</sec>
<sec><st>Conclusions</st>
<p>TDI is feasible in preterm neonates and enables the acquisition of myocardial velocities. With increasing gestation, higher myocardial velocities and lower E/E' ratios were found. The addition of TDI to standard neonatal echocardiography may provide additional information about cardiac function.</p>
</sec>
]]></description>
<dc:creator><![CDATA[Negrine, R. J. S., Chikermane, A., Wright, J. G. C., Ewer, A. K.]]></dc:creator>
<dc:date>2010-10-30T05:27:17-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.175109</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.175109</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Assessment of myocardial function in neonates using tissue Doppler imaging]]></dc:title>
<prism:publicationDate>2010-10-30</prism:publicationDate>
<prism:section>Short reports</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2009.180869v1?rss=1">
<title><![CDATA[Book review]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2009.180869v1?rss=1</link>
<description><![CDATA[ <p>Neonatology, it is said, is 10% emergencies and 90% waiting for those emergencies to happen. The unpredictable nature and timing of those emergencies means that senior skilled help is not always available immediately. <I>Neonatal Emergencies</I>, edited by Georg Hansmann, is written by experts from North America and Europe and constitutes a useful mix of readily accessible information covering emergencies that occur in the first 72 h of life (and sometimes beyond).</p> <p>It is, it must be said, not the only book of its kind on the market and most of us will have used at least one of the rival <I>Neonatal Handbooks</I> in the past (and probably become familiar with the layout of our favourites in doings so as they update themselves with new editions). As a new, and therefore unfamiliar, book it will need to offer something more to attract a readership and gain a good reputation. Fortunately,...]]></description>
<dc:creator><![CDATA[Ainsworth, S. B.]]></dc:creator>
<dc:date>2010-06-14T01:27:10-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2009.180869</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2009.180869</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Book review]]></dc:title>
<prism:publicationDate>2010-06-14</prism:publicationDate>
<prism:section>Postscript</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2008.137125v1?rss=1">
<title><![CDATA[Management of infantile spasms in a regional centre before and after the United Kingdom Infantile Spasms Study (UKISS)]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2008.137125v1?rss=1</link>
<description><![CDATA[
<p><P>The United Kingdom Infantile Spasms Study (UKISS) comparing hormonal treatment against vigabatrin in the management of infantile spasms showed that cessation of spasms was more likely in infants given hormonal treatment. </P>
<P>We believe this study has changed our practice and the advice we give colleagues across our region regarding the management of infantile spasms. We undertook this audit to see if this was confirmed.</P>
]]></description>
<dc:creator><![CDATA[Maheshwari, N., Zaiwalla, Z., McShane, M A]]></dc:creator>
<dc:date>2008-02-05T08:53:54-08:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2008.137125</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2008.137125</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[Management of infantile spasms in a regional centre before and after the United Kingdom Infantile Spasms Study (UKISS)]]></dc:title>
<prism:publicationDate>2008-02-05</prism:publicationDate>
<prism:section>Letters</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2006.114009v1?rss=1">
<title><![CDATA[The impact of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomized, controlled, community trial]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2006.114009v1?rss=1</link>
<description><![CDATA[
<p><P><B>Objective:</B> Micronutrient deficiencies during pregnancy may be linked to poor newborn health and host defenses against infection. We assessed newborn morbidity to determine the impact of four combinations of antenatal micronutrient supplements.
</P>
<P>
<B>Design:</B> Cluster-randomized, double-masked, controlled trial.  
</P>
<P>
<B>Setting:</B> Rural community in Nepal.
</P>
<P>
<B>Interventions:</B> Women received daily supplements from early pregnancy through 3 months postpartum of vitamin A alone (control) or vitamin A with folic acid, folic acid + iron, folic acid + iron  + zinc or a multiple micronutrient supplement containing these and 11 other nutrients. 
</P>
<P>
<B>Main outcome measures:</B> Infants were visited in their home at birth (n=3927) and for each of 9 days thereafter to elicit a 24-h history of 9 infant morbidity symptoms, measure infant respiratory rate and axial temperature, and assess the infant for chest indrawing. At 6 weeks of age, infants were visited again in their homes to elicit a 30-day and 7-day history of 10 morbidity symptoms using parental recall. 
</P>
<P>
<B>Results:</B> Maternal micronutrient supplementation had no impact on 10-d morbidity or morbidity 30-d and 7-d morbidity assessed at 6 wk of age; all relative risks were close to 1. Symptoms of birth asphyxia increased by about 60% (p&lt;0.05) in infants of women who received the multiple micronutrient supplement compared to the control.  Symptoms of combinations of sepsis, preterm, and birth asphyxia were associated with 8-14-fold increased odds of 6-mo infant mortality.  
</P>
<P>
<B>Conclusions:</B> None of the combinations of antenatal micronutrient supplements tested improved symptoms of neonatal morbidity in the first 10 days of life or at 6 weeks of age. Further research is needed to elucidate the association and mechanism of increased risk of birth asphyxia following maternal multiple micronutrient supplementation.</P>
]]></description>
<dc:creator><![CDATA[Christian, P. S, Darmstadt, G. L, Wu, L., Khatry, S. K, LeClerq, S. C, Katz, J., West, K. P, Adhikari, R. K]]></dc:creator>
<dc:date>2007-08-03T05:57:57-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2006.114009</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2006.114009</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[The impact of maternal micronutrient supplementation on early neonatal morbidity in rural Nepal: a randomized, controlled, community trial]]></dc:title>
<prism:publicationDate>2007-08-03</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
<item rdf:about="http://fn.bmj.com/cgi/content/short/adc.2006.105577v1?rss=1">
<title><![CDATA[High prevalence of vitamin D deficiency in newborns of high-risk mothers]]></title>
<link>http://fn.bmj.com/cgi/content/short/adc.2006.105577v1?rss=1</link>
<description><![CDATA[
<p><P><B>Objective:</B> To determine the prevalence of vitamin D deficiency in newborn infants of mothers at risk of vitamin D deficiency because of dark skin or the wearing of concealing clothes (such as a veil), compared with a group supposed not to be at risk. A second aim was to correlate these newborns&rsquo; vitamin D concentrations to biochemical parameters of vitamin D metabolism and bone turnover at birth. 
</P>
<P>
<B>Design:</B> A prospective study conducted between April 2004 and February 2006 including women delivering in this period, and their newborns.
</P>
<P>
<B>Setting:</B> Outpatient clinic of the obstetrics department, Sint Franciscus Gasthuis, Rotterdam, the Netherlands.
</P>
<P>
<B>Patients:</B> Eighty-seven newborns of healthy mothers either with dark skin and/or concealing clothing (risk group) or with light skin (control group).
</P>
<P>
<B>Results:</B> We found a significant difference in the prevalence of vitamin D deficiency (25-hydroxyvitamin D3 &lt; 25 nmol/l) between newborns born to mothers at risk and newborns born to mothers in the control group (63.3% vs. 15.8%; p&lt;0.0001). Mean alkaline phosphatase concentrations were significantly higher in the risk group.
</P>
<P>
<B>Conclusions:</B> Newborn infants of mothers with dark skin or of mothers wearing concealing clothes are at great risk of vitamin D deficiency at birth. Clinical implications are unknown. Further research is necessary to determine the long-term consequences of maternal and neonatal vitamin D deficiency in order to issue guidelines on vitamin D supplementation during pregnancy.</P>
]]></description>
<dc:creator><![CDATA[Dijkstra, S.H., van Beek, A., Janssen, J.W., de Vleeschouwer, L.H.M., Huysman, W.A., van den Akker, E.L.T.]]></dc:creator>
<dc:date>2007-04-25T07:53:37-07:00</dc:date>
<dc:identifier>info:doi/10.1136/adc.2006.105577</dc:identifier>
<dc:identifier>hwp:master-id:fetalneonatal;adc.2006.105577</dc:identifier>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<dc:title><![CDATA[High prevalence of vitamin D deficiency in newborns of high-risk mothers]]></dc:title>
<prism:publicationDate>2007-04-25</prism:publicationDate>
<prism:section>Original articles</prism:section>
</item>
</rdf:RDF>
